Homology-Based Functional Proteomics By Mass Spectrometry and Advanced Informatic Methods by Liska, Adam J.
Homology-Based Functional Proteomics 
By Mass Spectrometry and Advanced 
Informatic Methods 
 
 
D I S S E R T A T I O N 
 
zur Erlangung des akademischen Grades 
 
Doctor rerum naturalium 
(Dr. rer. nat.) 
 
vorgelegt 
der Fakultät Mathematik und Naturwissenschaften 
der Technische Universität Dresden 
von 
 
B.S. Biochem. Biol. Adam J. Liska 
 
geboren am 11. November 1976 in Lincoln, Nebraska, USA 
 
Gutachter:    Prof. Dr. Michael Göttfert, Technische Universität Dresden 
 Dr. Andrej Shevchenko, MPI of Mol. Cell Biology and Genetics  
 Prof. Dr. Michael O. Glocker, Universität Rostock 
 
Eingereicht am:   Oktober 2003 
 
Tag der Verteidigung: 
 
 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“all science is philosophy, whether it knows and wills it or not.” 
 
 
 
Martin Heidegger 
 
 
 
 
 
 
 
 
 4
Acknowledgements 
 
I would like to thank the exceptional staff of the Max Planck Institute of Molecular Cell Biology 
and Genetics in Dresden for addressing some of my domestic concerns as well as providing a 
great library resource. I thank my wife for daily supporting me through this research. I would 
also like to thank my collaborators for insight, suggestions, criticisms, and attention to detail, as 
well as those who provided technical assistance through the course of experiments: Professor 
Shamil Sunyaev (Genetics Division, Harvard Medical School, USA) for mathematics and 
bioinformatics collaborations concerning MS BLAST and MultiTag; Dr. Andrei Popov and 
Prof. Eric Karsenti (Cell Biology, EMBL, Heidelberg, Germany) for collaborations concerning 
Xenopus laevis cell biology; Prof. Peer Bork (Computational Biology EMBL, Heidelberg, 
Germany) for assistance in manuscript preparation and bioinformatics; Dr. Alexander Golod 
(Russia) for programming the MultiTag software; Dr. Adriana Katz and Prof. Uri Pick 
(Biological Chemistry, The Weizmann Institute of Science, Israel) for collaborations concerning 
Dunaliella salina biochemistry; Drs. Ignat N. Shilov, Subodh Nimkar, and Dan A. Schaeffer, 
(Applied Biosystems, Foster City, USA) for developing advanced mass spectrometry software 
to support our DB searching methods; Dr. Igor Chernushevich (MDS Sciex, Toronto, Canada) 
for assistance concerning quadrupole time-of-flight mass spectrometry; Dr. Peg Coughlin and 
Prof. Timothy Mitchison for Xenopus laevis spindle electron microscopy (Department of Cell 
Biology, Harvard Medical School, USA); Prof. Michael Brand and Prof. Michael Göttfert 
(Technische Universität Dresden, Germany) for being helpful members of my Thesis Advisory 
Committee; Dr. Bianca Habermann (Bioinformatics, MPI-CBG) for collaborations concerning 
MS BLAST database searching and phylogenetics; Dr. Jan Havlis (currently at the Department 
of Analytical Chemistry, Masaryk University, Czech Republic), Dr. Henrik Thomas, and Anna 
Shevchenko for assistance with mass spectrometry (MPI-CBG); and Dr. Andrej Shevchenko for  
mentoring me  through my dissertation research. 
 
 
 
 
 
 
 
 
 5
 
Summary  
 
Functional characterization of biochemically-isolated proteins is a central task in the 
biochemical and genetic description of the biology of cells and tissues. Protein 
identification by mass spectrometry consists of associating an isolated protein with a 
specific gene or protein sequence in silico, thus inferring its specific biochemical 
function based upon previous characterizations of that protein or a similar protein 
having that sequence identity. By performing this analysis on a large scale in 
conjunction with biochemical experiments, novel biological knowledge can be 
developed. The study presented here focuses on mass spectrometry-based proteomics of 
organisms with unsequenced genomes and corresponding developments in biological 
sequence database searching with mass spectrometry data. Conventional methods to 
identify proteins by mass spectrometry analysis have employed proteolytic digestion, 
fragmentation of resultant peptides, and the correlation of acquired tandem mass spectra 
with database sequences, relying upon exact matching algorithms; i.e. the analyzed 
peptide had to previously exist in a database in silico to be identified. One existing 
sequence-similarity protein identification method was applied (MS BLAST, 
Shevchenko 2001) and one alternative novel method was developed (MultiTag), for 
searching protein and EST databases, to enable the recognition of proteins that are 
generally unrecognizable by conventional softwares but share significant sequence 
similarity with database entries (~60-90%). These techniques and available database 
sequences enabled the characterization of the Xenopus laevis microtubule-associated 
proteome and the Dunaliella salina soluble salt-induced proteome, both organisms with 
unsequenced genomes and minimal database sequence resources. These sequence-
similarity methods extended protein identification capabilities by more than two-fold 
compared to conventional methods, making existing methods virtually superfluous. The 
proteomics of Dunaliella salina demonstrated the utility of MS BLAST as an 
indispensable method for characterization of proteins in organisms with unsequenced 
genomes, and produced insight into Dunaliella’s inherent resilience to high salinity. The 
Xenopus study was the first proteomics project to simultaneously use all three central 
methods of representation for peptide tandem mass spectra for protein identification: 
sequence tags, amino acids sequences, and mass lists; and it is the largest proteomics 
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study in Xenopus laevis yet completed, which indicated a potential relationship between 
the mitotic spindle of dividing cells and the protein synthesis machinery. At the 
beginning of these experiments, the identification of proteins was conceptualized as 
using “conventional” versus “sequence-similarity” techniques, but through the course of 
experiments, a conceptual shift in understanding occurred along with the techniques 
developed and employed to encompass variations in mass spectrometry instrumentation, 
alternative mass spectrum representation forms, and the complexities of database 
resources, producing a more systematic description and utilization of available 
resources for the characterization of proteomes by mass spectrometry and advanced 
informatic approaches. The experiments demonstrated that proteomics technologies are 
only as powerful in the field of biology as the biochemical experiments are precise and 
meaningful.   
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Shevchenko, Molecular and Cellular Proteomics, submitted), respectively. Section 2.3, “Dunaliella salina 
Functional Proteomics”, contains material submitted for publication in the article, “Homology-Based 
Proteomics By Mass Spectrometry Reveals Aspects of Salinity Adaptation in Dunaliella ” (Liska A.J., A. Katz, 
A. Shevchenko, and U. Pick, Plant Physiology, submitted). Section 2.4 contains material previously published 
and submitted for publication in “Expanding the Organismal Scope…” and “Homology-Based Functional 
Proteomics…”, respectively. Section 2.5 contains material previously published in “Combining Mass 
Spectrometry with Database Interrogation...”  
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1 Introduction 
1.1 Mass Spectrometry-Based Proteomics and Biological Sequence 
Database Searching 
1.1.1 Technological Developments in Biology and the Emergence of Proteomics 
A number of technologies are revolutionizing biological research. Molecular biology has 
mastered the detection and manipulation of genes by specific nucleases, PCR, Northern & 
Southern blot, microarray technology, RNA interference, and cell transformation by 
homologous recombination, among other techniques. At the same time, high-throughput 
DNA sequencing has paved the way for ‘shotgun’ whole genome sequencing. 
Developments in protein biochemistry now allow proteins to be isolated specifically from 
cells along with selective isolation of interacting protein partners. Technical and 
computational advances now enable mass spectrometry (MS) to ionize proteins and 
peptides into the gas phase with high yields, and determine their masses with high accuracy, 
creating a direct tie between analyzed protein fragments and database (DB) sequences 
(genes) in a matter of minutes.  This series of tools allows unprecedented levels of 
molecular analysis of proteins and genes in living cells. Now proteins and the genes that 
give cells their unique properties can be examined rapidly and accurately, thus advancing 
the development of theoretical biological knowledge, applied biotechnology and the 
biomedical sciences to a high degree. Developments in the related fields above have 
enabled proteomics to arise in the biological sciences.    
Proteomics is the characterization of groups of proteins that are found in specific 
cells or tissues[1]; the proteome is defined as the protein complement of the genome; the 
genome being the cells complete set of DNA. Proteomics research is carried out in order to 
characterize cellular protein complexes or organelles in cell biology, analyze gene 
expression patterns[2], and interrogate genes and genomes. The first problem in conducting 
proteomics is the development of accurate and versatile protein identification strategies. 
Although it has been possible to purify proteins using established methods of biochemistry, 
the crucial step in the characterization of any proteome is high-throughput protein 
identification. Protein identification by MS consists of associating a biochemically-isolated 
protein with a specific gene or protein sequence in silico, thus inferring its specific 
biochemical function based upon previous characterizations of that protein or a similar 
protein having that sequence identity. By performing this on a large scale in conjunction 
with biochemical experiments, novel biological knowledge can be developed.   
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In proteomics, MS has become a powerful analytical technology to identify proteins 
by the analysis of peptides and the correlation of resultant mass spectra with available DB 
sequences (reviewed in[3,4]). Genomic sequencing projects, which supply the majority of 
sequences for databases, are a relatively new phenomenon in the biological sciences and 
thus have only a few representative complete genomes to show for their efforts, however 
significant the development of these efforts may be[5]. However recently many important 
organisms have had their genomes sequenced, such as human[6,7], mouse[8], rice[9,10], 
Arabidopsis[11], and the pufferfish[12]. Using established MS techniques, a limited DB 
resource has not been conducive for facile protein identification from species with 
unsequenced genomes. Yet despite the relative deficiency of genomic sequences compared 
to a whole biosphere of living species, the emerging interplay of MS and bioinformatics is 
significantly expanding the organismal scope of proteomics.   
 
1.1.2 Cross-Species Protein Identification by Mass Spectrometry  
Irrespective of whether the genome of a species is sequenced or not, the identification of 
proteins by MS consists primarily of two analyses of peptides produced by proteolytic 
digestion of purified whole proteins. Matrix-assisted laser desorption/ionization time-of-
flight (MALDI TOF) MS produces spectra by the resolution of intact peptides according to 
their masses, and identifies proteins by the correlation of these masses with theoretically 
calculated masses of peptides from DB entries; a method defined as peptide mass 
fingerprinting (PMF). The second type of analysis, tandem mass spectrometry (MS/MS), 
produces patterns of peptide fragments that can be correlated to DB entries in a number of 
ways (see section 2.5.2). 
Using MS and available protein DB sequences, cross-species protein identifications 
are accomplished by partially aligning analyzed peptides from a protein from a species with 
an unsequenced genome to a DB sequence from a related species. After DNA sequencing 
projects began, it became apparent that phylogenetically related species have significant 
genomic sequence co-linearity and their proteins have a high degree of homology[5]. 
However, gene sequences are rarely identical from one species to another and genes are 
normally riddled with nucleotide substitutions, resulting in amino acid substitutions in 
proteins. As organisms become more phylogenetically distant from one another or as certain 
genes become altered at higher rates, homologous genes and their corresponding proteins 
retain a lower percentage of identity.   
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PMF enables cross-species protein identification in some cases because only a 
subset of all peptides from a protein digest needs to be recognized[13,14]. Those peptides 
that have amino acid substitutions and corresponding shifts in mass are not recognized and 
don’t contribute to the identification. The theoretical predictions by Wilkins and Williams 
proposed that proteins can be identified using PMF if the analyzed protein and reference 
DB entry have >80% sequence identity, although the authors added that these cases would 
need to be supported by further evidence for validation. The high mass accuracy of modern 
TOF and Fourier transform ion-cyclotron resonance mass spectrometry (FTMS) instruments 
increases confidence in cross-species PMF and loosens the sequence identity requirement, 
as less peptide masses would be required to produce a confident hit[15].  
For proteins with a lower sequence identity compared to available sequences, the 
more specific MS/MS analysis of peptides provides confident cross-species identifications 
with a few peptide sequences, depending on the length and significance of their amino acid 
composition.  In this method, masses of precursor ions and fragment ions (from MS/MS) 
are submitted for DB searching using specialized software (reviewed in[16]). Regardless of 
differences in DB searching algorithms and MS platforms, the conventional softwares 
correlate the observed masses with theoretically predicted masses derived from peptide 
sequences produced by in silico digestion of protein DB entries, and calculates the 
statistical significance of matches. Importantly, these softwares do not require a full 
representation of the fragment ions in the tandem mass spectrum and can positively identify 
the peptide even if only some of the fragment ions are matched. The significance of hits 
increases if more fragment ions are detected and if more than one peptide sequence 
originating from the same DB entry is recognized. Thus conventional DB mining software 
is inherently biased towards exact matching of spectra (and corresponding peptides) to 
catalogued sequences, and in practice it is mostly applied to the identification of proteins 
already residing in available databases. It is therefore not surprising that proteomics is 
largely limited to organisms with sequenced genomes, despite the fact that phylogenetically 
related species share significant molecular homology and that extensive protein sequence 
information may be available from related species.  
Where PMF and non-error-tolerant MS/MS methods fail, the identification of 
proteins in the past has relied primarily on predicting amino acid sequences from MS/MS 
spectra and using the predicted sequences to identify proteins by their similarity to existing 
databases entries (Figure 1).  
 
 15
 
Protein 
Enzymatic Digestion 
Peptide Mixture
MS
Database
Search
Identification
MS/MS 
Sequence 
Similarity 
Database
Search
Non-Error-
Tolerant
Database
Search
 
Figure 1  Strategy for cross-species protein identifications by mass spectrometry.   
Proteins are identified by the analysis of peptides by either MS or MS/MS.  A DB search follows each analysis.  
From MS/MS spectra, the less sensitive non-error-tolerant route or the more sensitive sequence-similarity 
search route are used for protein identification depending on the sequence of the analyzed protein and available 
database resources. 
 
 
1.1.3 Mass Spectrometry Platforms 
Historically, the first mass spectrometry platform (MSP) for protein identification included 
2-D PAGE and MALDI TOF MS for PMF (reviewed in[17]). MALDI-TOF is most 
commonly used in proteomics in ion reflection mode because of its low femtomole (even 
attomole) sensitivity and high resolution (>10,000 full width at half maximum, FWHM). 
Peptide mass fingerprints are routinely acquired with better than 50 ppm mass accuracy 
with external calibration, and recently reported automated re-calibration methods lower the 
error of mass measurement below 10 ppm[18,19]. MALDI spectra can be acquired very 
rapidly, and the entire routine, starting from digestion of proteins, preparation of the 
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MALDI probes and acquiring the spectra, is now automated and optimized for a very high 
throughput[20,21]. 
MALDI identification capabilities can be additionally strengthened by the 
acquisition of post source decay (PSD) spectra for a few selected peptide ions[22]. 
However, acquisition of PSD spectra is rather slow and it is much less sensitive compared 
to peptide fingerprinting, fragmentation is poorly controlled, and the spectra suffer from 
low resolution and mass accuracy, and therefore the technology has not had a significant 
impact in proteomics. However the recently introduced LIFT method[23] speeds up 
acquisition of MALDI PSD spectra considerably.  
MALDI MS/MS capabilities are mainly explored through the development of 
instruments with combined mass analyzers, such as MALDI-quadrupole TOF (Q(q)TOF) 
mass spectrometers[24,25] and MALDI-TOF/TOF[26]. Both instruments can acquire high 
mass accuracy peptide fingerprints, and enable the control of collision energy in MS/MS 
mode. However, because of the orthogonal configuration of the ion path, MALDI-Q(q)TOF 
machines can acquire MS/MS spectra at relatively low collision energy, with the same 
resolution (>12,000) and mass accuracy (<20 ppm) as in the MS mode[27].  
Regardless of the employed mass analyzers, MALDI sources predominantly ionize 
tryptic peptides as singly charged ions. To fragment singly charged ions, higher collision 
energy is required and therefore cleavage of amide bonds in the peptide backbone occurs 
less consistently. Usually MALDI MS/MS spectra do not contain continuous ion series that 
facilitate the confident determination of long peptide sequences. A number of peptide 
derivatization methods, localizing the charged groups at the N- or C-terminus of the 
molecule, have been developed to improve peptide fragment patterns[28,29]. MALDI 
sources have also been coupled with an ion trap, allowing the acquisition of MS/MS spectra 
very rapidly, albeit mass accuracy of the ion trap is much lower compared to TOF 
analyzers[30]. However, a large number of acquired MS/MS spectra increases the 
specificity of DB searching, and compensates the lack of specificity of DB searching with 
peptide mass fingerprints, which is heavily dependant on mass accuracy.  
Electrospray ionization (ESI) methods form another major cluster of MS platforms. 
In ESI MS, tryptic peptides are typically ionized as doubly or triply charged ions. Multiply 
charged ions can be efficiently fragmented at lower collision energy, and their MS/MS 
spectra are usually dominated by intense y- and b-ions (see[31] for the nomenclature), 
which facilitates DB searching and also makes the spectra more amenable for de novo 
interpretation[32]. 
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Peptides can be either separated by liquid chromatography on-line with the mass 
spectrometer (LC-MS/MS), or alternatively, unseparated peptide mixtures may be directly 
analyzed by nanoelectrospray mass spectrometry (NanoESI)[33]. The absence of separation 
in NanoESI is compensated by much longer spraying time per spectrum, which is made 
possible by low flow injection rates (20 – 30 µL/ min), and many precursor ions can be 
fragmented successively[34]. However, NanoESI-MS/MS experiments are limited by the 
ability of the operator to recognize low abundance precursors masked by chemical noise. 
The specificity of precursor ion detection can be increased via precursor ion scanning for 
abundant immonium ions of amino acid residues (typically, of Leu and Ile)[35]. Precursor 
ion scanning is a routine operation mode of triple quadrupole (TQ) mass spectrometers and 
recently it has been set up also on Q(q)TOF machines[36,37]. Although fewer peptide 
precursor ions are typically fragmented in the course of NanoESI-MS/MS analysis, the 
quality and signal-to-noise ratio in their fragment spectra are routinely better than by LC-
MS/MS, because the data accumulation time and collision energy can be precisely tuned by 
an operator during the acquisition process. However, NanoESI-MS/MS is relatively 
difficult to automate[38] and it has a limited ability to identify proteins in complex 
mixtures. 
By pre-separating peptides in front of the on-line mass spectrometer, analytical 
methods gain higher dynamic range and ability to identify proteins in very complex 
mixtures[39]. By applying this method a substantial part of the proteomes of prokaryotic 
and low eukaryotic organisms can be characterized[39-41]. Further coupling of 
multidimensional LC-MS/MS analysis enables relative quantification that utilizes peptides 
enriched with stable isotopes as internal standards, and promises global survey of 
quantitative changes in the proteomes[41-43]. However, there is less control in the process 
of spectra acquisition, and information content of MS/MS spectra might be compromised. 
This might not be particularly important for protein identification by pattern searches (see 
later section) because with high resolution of instruments the ion statistics in the peak does 
not strongly affect mass accuracy, and full representation of fragments in the spectrum is 
not required[27]. However, poor ion statistics affects the accuracy of de novo sequencing, 
which benefits from recognizing complementary pairs of fragment ions and the full 
representation of low molecular weight peaks is often critical.  
Because of differences in ionization mechanisms, MALDI and ESI produce 
different data sets when the same protein digest is analyzed[44,45]. Parallel analysis of 
digests by two methods increases the sequence coverage of peptide maps, but usually 
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requires the employment of different instrumentation. Rapidly switchable combined 
MALDI/ESI sources[46,47] allow changing between ionization modes within minutes 
without venting the mass spectrometer, and might provide an effective alternative to 
expanding costly instrumentation. 
Other MSPs such as MALDI- and ESI-Fourier transform ion cyclotron mass 
spectrometry (FTMS)[48,49], linear ion trap[50], and ion trap-TOF[51] mass spectrometers 
are employed in proteomics, but are currently less prevalent. Depending on the type of mass 
spectra, specific types of databases (protein, EST, or genomic) can be interrogated with 
more or less efficiency.  
 
1.1.4 Efforts Towards the Identification of Proteins by Tandem Mass Spectrometry 
and Sequence-Similarity Searches 
The new instrument configurations described above have greatly contributed to large-scale 
protein identification. However, the increasing analytical precision and sensitivity of mass 
spectrometers does not necessarily lead to improved success in the identification of proteins 
from species with unsequenced genomes. A central analytical consideration is the inability 
to always reconstruct a complete and accurate amino acid sequence from tandem mass 
spectra of peptides (Figure 2). Usually these spectra can only be partially interpreted due to 
the natural under-representation of peptide fragment ions and because of the presence of 
chemical noise, which may obscure peptide fragments of low intensity and misguide 
spectrum interpretation. To overcome this difficulty, methods for the chemical 
derivatization of peptides, and alternate methods of interpreting spectra and DB searching 
have been developed. 
 De novo interpretation of tandem mass spectra relies on measuring the mass 
differences between adjacent fragment ion peaks of one of the major ion series, i.e. b-series 
(ions containing N-terminus) or y-series (ions containing C-terminus), which are more 
common in tryptic peptides ionized by electrospray, resulting in the prediction of an amino 
acid sequence (see[31] for the nomenclature). Upon collision-induced dissociation (CID), 
tryptic peptides tend to break at the amide bonds between consecutive amino acid residues 
producing a continuous y-ion series of fragments; an amino acid sequence can be 
determined by measuring the mass difference between consecutive y-ions; this relies upon 
the varying mass values of different amino acid residues.  One method to facilitate this 
interpretation is to enrich a series of fragments by attaching a strongly positively or strongly 
negatively charged group to the N-terminus of peptides[28,29].  Another method is to 
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introduce an isotopic label to the C-terminus of peptides by digesting proteins in a buffer 
containing H218O (protocols reviewed in[52]) or by CD3OH[53]. 18O-labeled y-ions can be 
recognized by a one or two Thomson shift (depending on the peptides fragments charge) 
and allow confident readout of a peptide sequence[54]. These methods have enabled the 
cloning of a few proteins via oligonucleotide primers and PCR[55].  However, usually 
abundant amounts of protein are required, spectra interpretation remains laborious and time 
consuming, and therefore these approaches have never been applied in large-scale projects.  
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Figure 2  Interpretation of a peptide tandem mass spectrum.  
The MS/MS spectrum of a doubly charged precursor ion with m/z 883.44 was acquired by fragmentation on a 
quadrupole time-of-flight mass spectrometer.  Manual interpretation of spectra considered precise mass 
difference between adjacent y-ions starting from the m/z segment above the precursor ion (corresponding peaks 
and amino acid residues are designated by arrows).  Automated interpretation resulted in a few partially 
redundant sequences covering the C-terminus of the peptide (inset).  The underlined sequence was matched to 
bovine DNA Polymerase.  The symbol Z represents the amino acid Q or K (delta 0.036 Daltons).  The symbol 
X represents an unknown amino acid. 
 
A second possibility is to interpret tandem mass spectra of peptides using 
specialized software that creates amino acid sequences de novo[56,57]. Although the 
software utilizes different computational principles, sequences of short peptides can be 
produced rapidly and accurately. However, less confident sequences and/or incomplete 
sequences are usually deduced from spectra of large and/or triply charged ions. For each 
spectrum, the software produces a list of candidate peptide sequences that are ranked in the 
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order according to their scored confidence. However, the absence of a rigorous scoring 
system may lead to erroneous identifications as the correct sequence may be present in the 
list, but may not be ranked among the top hits. Even though it is difficult to use these 
sequences for cloning (where the requirement is that the sequences should be long, 100% 
accurate, and encode for low degeneracy primers), they can be successfully used for 
identifying proteins in a sequence DB using various sequence-similarity search algorithms.  
The use of BLAST[58] or FASTA[59] DB searching engines to analyze peptide 
sequences produced by interpretation of tandem mass spectra is not straightforward because 
both algorithms have been optimized for comparing long and accurate protein sequences, 
whereas the interpretation of tandem mass spectra yields sets of short inherently-redundant 
and error-prone sequence candidates. Furthermore, it is not known in what order the peptide 
sequences should be aligned on the backbone of the polypeptide, if those sequences belong 
to a single protein or originate from a few proteins co-migrating within a single 
chromatographic gel band (or spot), nor what isobaric amino acids are present (such as, Leu 
and Ile, Lys and Gln, or Phe, or Met–sulphoxide). 
To address these difficulties, common DB search engines have been manipulated to 
allow the input of sequences produced by MS. Modified FASTA-based software is 
available as stand-alone applications[57,60,61], whereas MS BLAST (Mass Spectrometry 
driven BLAST DB searching[62]) is accessible over the internet (http://dove.embl-
heidelberg.de/Blast2/msblast.html). The limitations of FASTA-based algorithms are that 
they are slow search engines and the final score of hits depends not only on the number of 
matched peptides, but decreases with the number of candidate peptide sequences submitted 
in a query (the significance of all DB searches decreases with the increasing size of the 
query; i.e. the number of fragmented peptides). This aspect of the software means that 
spectra must be represented by as few putative amino acid sequences as possible, which is 
difficult to do because of the inherent ambiguity of automated interpretation of tandem mass 
spectra, as well as the difficulty to create one sequence prediction by manual interpretation. 
If DB searching with the predicted sequences makes no alignment, researchers are unable to 
ascertain whether the spectra were misinterpreted or no corresponding sequence exists in a 
DB. However, FASTA-based engines are flexible, may engage optional gapped alignment, 
and the statistical apparatus is specifically tailored for matching short peptide sequences. 
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Figure 3  MS BLAST sequence alignment of an analyzed unknown protein from Xenopus laevis. 
Manual and automated de novo sequence prediction of 21 tandem mass spectra from fragmented tryptic 
peptides resulted in 792 putative peptide sequences submitted to a search string.  Bovine DNA polymerase was 
the top hit; matching 10 peptides.  Multiple hits from different organisms were retrieved from the MS BLAST 
search and many were able to make high confidence matches (see Table 4.) 
 
The MS BLAST software has a particular advantage of being very fast in searching 
and not penalizing the score of hits for submissions of numerous redundant putative 
sequence candidates (Figure 3)[62]. This allows direct submission of the entire output of the 
sequence prediction software for all fragmented peptides, without intermediate inspection of 
data and arbitrary selection of the most reliable hits. This quality allows MS BLAST to be 
coupled with high-throughput sequencing techniques such as MALDI-TOF/TOF, MALDI-
QqTOF and LC/MS/MS through a simple scripting interface[63]. Importantly, both MS 
BLAST and FASTS methods provide independent means of evaluating the statistical 
significance of alignments, and therefore it is not necessary to compare retrospectively the 
matched peptide sequences with actual tandem mass spectra to rule out false positive hits. 
When trying to identify proteins by sequence-similarity searches, the number of 
peptides recognized from a digested protein determines the success of the identification. It 
has been calculated that as more peptides are analyzed and matched, proteins of lower 
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homology to DB sequences can be identified with the limit being around 50% identity (this 
is dependent on which software is used)[61]. Since mass spectrometric analysis rarely 
reconstructs a complete sequence, the percent identity of the analyzed protein compared to 
the matching DB sequence is unable to be determined without extended analysis.   
Besides these statistical considerations, when investigating the proteome of an 
organism with an unsequenced genome, the ability to identify proteins is dependent on the 
content of available databases. Where an abundance of DB sequences exist from closely 
related organisms, with respect to the organism under inquiry, more homologous genes 
exist in silico to make cross-species identifications possible.  If the organism being studied 
is very distantly related to any organism with a sequenced genome, the likelihood of protein 
identification decreases because of the decrease in the number of homologous genes in 
silico. 
 
1.1.5 Organismal Diversity in Functional Proteomics: Orthologous Protein Complexes 
and Protein Interaction Networks 
The availability of genomic sequences and progress in gene manipulation technologies has 
shifted the focus of functional proteomics from the identification of individual proteins 
towards deciphering of protein complexes and their place in a global protein interaction 
network[64,65]. As protein complexes are often regarded as functional units of the 
molecular machinery of the cell[66], their characterization provides mechanistic insight into 
key regulatory processes and facilitates functional interpretation of genomic sequences. 
As many cellular functions are conserved throughout a variety of species, it has 
been inferred that orthologous protein complexes might also share similar composition and 
architecture[5]. Comparison of three native protein complexes, isolated from budding yeast 
cells and from human cells by immunoaffinity chromatography, supports this notion[64]. 
Thus, it is conceivable that conserved protein complexes may be initially characterized in a 
model organism and then the obtained knowledge can be projected on orthologous 
complexes in other organisms, including humans. There are several lines of evidence why 
such a strategy will benefit from wider representation of model organisms, which might 
have uncharacterized or partially sequenced genomes. 
 A combination of biochemical isolation of protein complexes and mass 
spectrometric identification of their subunits provides the most detailed characterization of 
their composition and organization. However, the abundance of orthologous complexes 
varies greatly between different species and cell types (and hence their ability to be 
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identified by MS) and so does the completeness of their biochemical characterization. The 
study of complexes is also facilitated by a multitude of investigative methods that 
differentially suit distinct specimens. Some species are more amenable to genetic 
manipulation than others, while some are more easily studied under a microscope. The 
characterization of complexes is best accomplished through the study of more than one 
species, applying a set of different investigative methods, with MS being a major 
participant.  
Orthologous protein complexes are seldom identical, even if they comprise subunits 
with a high degree of homology. For example, a complex of aminoacyl-tRNA synthetases 
in budding yeast contains three subunits: Glu-tRNA synthetase, Met-tRNA synthetase, and 
the non-aminoacyl-tRNA synthetase component Arc1p[67]. Despite the fact that 
orthologous yeast and human aminoacyl-tRNA synthetases share substantial sequence 
identity, the orthologous complex in higher eukaryotes comprises nine aminoacyl-tRNA 
synthetases and three non-aminoacyl-tRNA synthetase components: Arg-tRNA synthetase, 
Asp-tRNA synthetase, Gln-tRNA synthetase, Ile-tRNA synthetase, Leu-tRNA synthetase, 
Lys-tRNA synthetase, Met-tRNA synthetase, bifunctional Glu-Pro-tRNA synthetase, and 
p18, p38, p43[67]. Thus, characterization of the complex only in lower organisms or only in 
higher organisms provides limited knowledge of its architecture and function in general. 
Most importantly, even if orthologous complexes are very similar in composition, 
they might be regulated via interaction with different, non-orthologous proteins or protein 
complexes. Orthologous cell cycle regulating ubiquitin ligases in yeast and human serve as 
a good example. The SCF complex (termed for Skp1–Cdc53–F-box protein) is built from 
conserved core subunits: Skp1, cullin homologue Cdc53, and RING H2 subunit Hrt1 
(reviewed in[68]). The recruitment of various adaptor proteins, which share the F-box 
sequence motif, forms an array of distinct ubiquitin ligases with different substrate 
specificity. SCF complex was immunoaffinity isolated from human and yeast cells using the 
epitope-tagged cullin subunits cul1[69] and cdc53[70], respectively, as baits. Comparison of 
the patterns of co-immunoprecipitated proteins revealed orthologous core proteins, along 
with a pool of F-box adaptors. However, eight subunits of the signalosome complex (CSN), 
a conserved 500 kDa protein assembly originally discovered in Arabidopsis[71], were 
found in association with cul1 from human and not yeast. Subsequent experiments 
suggested a possible role of the CSN in regulating of ligase activity[69]. Interestingly, the 
budding yeast genome only encodes for the apparent ortholog of a single subunit of CSN-
CSN5, which is called Rri1[72]. However neither Rri1, nor its interaction partners 
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suggested by two-hybrid screening[73] or by systematic analysis of protein 
complexes[64,65], were detected in the immunoprecipitate of tagged cdc53. Thus critical 
insight into the regulation of the conserved ubiquitin ligase complex SCF by another 
conserved complex CSN came from the isolation and comparative analysis of complexes in 
multiple species, rather than via expanding the pattern of interactors identified in a single 
model organism.  
 
1.1.6 Developments in Genomic Sequencing, Biological Sequence Databases, and 
Proteomics by Mass Spectrometry  
The development of automated high-throughput DNA sequencing in the early 1990’s made 
necessary technical advances for genomic sequencing. The first living organism to be 
sequenced was Haemophilus influenzae, in 1995. Since the completion of the first genome, 
many unicellular and multicellular eukaryotic organisms’ genomes have been sequenced, 
including S. cerevisiae, E. coli, C. elegans, D. melanogaster, A. thaliana, and the crowning 
achievement of the first draft assembly of the human genome[6,7]. Genomic sequencing 
continues at a very high rate with the completion of a new organism every few months, if 
not weeks.  
Protein sequence databases are continually updated with submissions produced 
from the cloning of genes, from which amino acid sequences are generated by translation of 
nucleotide sequences in their correct reading frames (www.ncbi.nlm.nih.gov, 
www.expasy.org/sprot/, www.ebi.ac.uk/). Whole-genome shotgun sequencing also 
produces large sets of nucleotide sequences that are assembled into contiguous sequences 
(i.e. whole chromosomes). As these genomic sequences are evaluated by gene prediction 
methods and open reading frames are designated, protein sequence is generated on the basis 
of nucleotide sequence and contributed to growing protein sequence databases (see[74] for 
review). Besides the sequencing of individual genes or genomic DNA, messenger RNA 
(mRNA) is isolated to generate complementary DNA (cDNA) libraries. cDNAs are then 
partially sequenced to produce expressed sequence tag (EST) nucleotide sequence 
databases[75]. Often cDNAs are translated to protein sequences and submitted to databases. 
In the hands of the mass spectrometrist, all three types of DB (protein, EST, and genomic) 
may be interrogated with mass spectra.  
With this first completed genome, biologists began to identify large sets of proteins 
from Haemophilus influenzae using 2-D gels and MS via PMF[76]. With the completion of 
the sequencing of genomes other organisms, research into the proteome of these organisms 
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began to follow by a variety of MS techniques. These efforts have been extensive and more 
research has been accomplished than can be cited here.  
The research community that uses MS for protein identification has made a habit of 
identifying proteins from only those organisms with sequenced genomes, because of the 
ability to easily translate those sequences and correlate them with analyzed proteins in a 
number of ways, as shown above. However, using MS and advanced methods of DB 
interrogation, it is becoming increasingly possible to study the proteomes of species with 
unsequenced genomes. Cross-species identifications have been made in these species and 
others not cited: Zea mays[77,78], Pisum sativum[79,80], Papaver somniferum[81], 
Spinacia oleracea[82], Arabidopsis thaliana[82], Bos taurus[83], Xenopus laevis[84,85], 
Pichia pastoris[62], and Trypanosoma brucei[60,61]. Many earlier studies utilizing cross-
species identification of unknown proteins have relied on high mass accuracy MALDI-TOF 
PMF, and therefore may have identified highly abundant proteins or enzymes conserved 
across the biosphere. As more sequence-similarity-based methods are being developed and 
applied, the proteomics of organisms with unsequenced genomes can be envisioned to 
become more productive and insightful by being able to identify a wider breadth of 
proteins, i.e. less conserved proteins in closely related species and conserved proteins in 
distantly related species. 
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1.2 Questions and Aims of the Thesis 
 
Researchers desire to apply proteomics methods to a breadth of species with unsequenced 
genomes in an attempt to solve many practical problems and characterize species more 
thoroughly at the molecular level. The focus of this thesis was to extend the high-
throughput capabilities of mass spectrometric protein identification to these organisms. 
Three goals were to be met during the research: 
 
 
 
1. Extend the capabilities of the MS BLAST method to nanoelectrospray Q(q)TOF 
mass spectrometry for high-throughput analysis; and establish a standard pipeline 
for protein analysis. 
 
 
 
2. Develop a method based on error-tolerant sequence tags for sequence-similarity 
protein identification to complement the capabilities of MS BLAST. This method 
should be applicable for high-throughput analysis. 
 
 
 
3. Apply the sequence-similarity methods above to problems in cell biology of species 
with unsequenced genomes.  
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2 Results and Discussion 
2.1 Development of the MultiTag Sequence-Similarity Protein 
Identification Method 
2.1.1 The Sequence Tag for Peptide Mass Spectrum Interpretation 
A major limitation to sequence-similarity protein identification rests in the quality of de 
novo interpretation of tandem mass spectra, rather than in DB searching. Tandem mass 
spectra imperfectly represent the structure of any peptide because upon CID only some 
peptide fragments are detected which could indicate the amino acid sequence of the peptide. 
At the same time, spectra often display unpredictable ions that originate from fragmentation 
of the side chains of amino acid residues, or other fragmentations (or chemical noise), and 
are not accounted for by typical scoring schemes applied by software for spectra 
interpretation. It is common in peptide sequencing at femtomole concentrations that low 
peptide content and high chemical noise allows only a few informative fragment ions to be 
detected in MS/MS spectra, from which software-assisted interpretation can not produce 
credible full-length peptide sequence proposals, and subsequent sequence-similarity 
identification will likely be ineffective for protein identification.  
The peptide sequence tag approach for error-tolerant database searching developed 
by Matthias Mann and Matthias Wilm in 1994 helps to overcome those limitations[86]. The 
sequence tag utilizes a short (2-4 amino acid residue) sequence stretch, (which can be easily 
determined from low energy CID spectra acquired from multiply charged precursors) and a 
pair of masses that lock the determined stretch in the full length peptide sequence; namely 
the combined mass of all amino acids between the N-terminus of the tryptic peptide and the 
identified regions, and the mass of all amino acids between the identified region and the 
tryptic peptide’s C-terminus (Figure 4). In stringent DB searches both masses and the 
sequence are required to match. Currently, sequence tags are employed in protein[87], 
EST[88], and genomic sequence[82] DB searching. However no statistical evaluation of the 
significance of matches is provided in these searches. Therefore even if a single hit was 
retrieved upon DB searching, the match between corresponding peptide sequence from a 
DB entry and the tandem mass spectrum has to be verified retrospectively by manual 
inspection; i.e. the predicted fragment ions corresponding to those produced by the 
theoretical CID of the respective peptide sequence must be overlaid on the spectrum, taking 
note particularly of coincidence of y-ions in the m/z region above the multiply-charged 
precursor. 
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Figure 4  Analysis of a Xenopus protein by MS and construction of a sequence tag. 
 
Xenopus proteins were in-gel digested and analyzed by nanoelectrospray tandem mass spectrometry. MS 
spectrum peaks labeled with a * were fragmented and peptide sequence tags were constructed from MS/MS 
spectra (inset). Abundant y-ions above the multiply charged precursor in MS/MS spectra allow direct 
determination of the partial amino acid sequence of a peptide and corresponding sequence tag construction. 
Peaks in the MS spectrum labeled with a T belong to trypsin. The resulting sequence tag from the MS/MS 
spectrum shown is (587.36)VSQ(901.52), parent mass 1047.55. All of the determined sequence tags from the 
analysis of this sample are found in Table 1. The protein was identified as Isoleucyl-tRNA synthetase. 
 
Sequence tags can be used for error-tolerant searching allowing one of the regions 
of the sequence tag (and, consequently, the intact mass) to mismatch. The approach enables 
cross-species identifications in protein sequence databases[54]. However, loose matching 
requirements result in a dramatic loss of search specificity so that typically many hundreds 
of hits are retrieved, and manual inspection of all of them is tedious.  
In the experiments below, the capability of the sequence tag search has been 
extended with the implementation of a statistical evaluation for the matching of multiple 
partial sequence tags in the identification of proteins from organisms with unsequenced 
genomes. Here the MultiTag (MT) approach is demonstrated to enable the identification of 
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distantly related proteins by sequence-similarity searching using only very short stretches of 
peptide sequence retrieved from tandem mass spectra, and is therefore a vastly simplified 
and sensitive method of exploring the proteomes of organisms with unknown genomes.  
 
2.1.2 MultiTag Protein Identification Strategy 
MT is a sequence-similarity searching approach for identifying unknown proteins via their 
homology to known proteins available in sequence databases. Comparison of homologous 
sequences of proteins from different species often shows that varying amino acid residues 
are distributed randomly along a polypeptide backbone, with some regions having more 
conservation than others. Although a single tryptic peptide may not be completely identical 
between the two protein sequences, their partial identity frequently occurs (Figure 5) Error-
tolerant searching with sequence tags can reveal regions of partial identity without 
determining complete peptide sequences. Although those regions are rather short to claim 
positive identification of a protein homologue, typically many peptides are sequenced from 
a protein digest. The MT software reveals proteins to which multiple fragmented peptides 
are matched in an error-tolerant fashion and computes the statistical significance of the hits 
to discriminate true hits from false positives. 
 The first step of the analysis is the construction of peptide sequence tags based on 
raw mass spectra (Figure 6). Sequence tags are typically called from the high m/z region of 
tandem mass spectra of tryptic peptides, which are dominated by abundant y-ions and 
partial interpretation of the spectrum is straightforward. Sequence tags were assembled for 
as many fragmented tryptic peptides as possible and were used for searching a DB in a 
stringent fashion (matching regions 1, 2 and 3) and error-tolerant fashion; a search 
tolerating a mismatch of the C-terminal mass (matching regions 1 and 2); a search tolerating 
a mismatch of the N-terminal mass (matching regions 2 and 3); and searches tolerating one 
mismatch in the amino acid sequence (matching regions 1 and 3); the hits were additionally 
encoded by the mass of the precursor ion and by the abbreviated matching region (NC, N, 
C, or E, respectively) in the sequence tag. Importantly, matches of retrieved sequences to 
corresponding tandem mass spectra were not further inspected, and the redundant hits 
(matching the same peptide sequence in another DB entry, or in another search) were not 
removed. If stringent searches (i.e. with regions 1, 2 and 3 matched) retrieved many 
candidate sequences no additional verification of hits was performed. The full list of hits 
was then submitted to the MT program. The software identified multiple hits originating 
from the same protein entry, eliminated redundant hits to the same peptide in the same entry 
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and assigned the significance to all matches by computing an estimate of the probability 
that such a combination of tags may hit a protein entry at random. 
 
 
 
 
 
 
Human            --MSTAGK  VIK  CK  AAVLWEVK  KPFSIEDVEVAPPK  AYEVR IK  MVAVGICR  
Alligator        ---    STAGK  VIK  CK  AAITWEIK     KPFSIEEIEVAPPK    AHEVR IK    ILATGICR  
 
TDDHVVSG-NLVTPLPVILGHEAAGIVESVGEGVTTVKPGDK   VIPLFTPQCGKCRVCKNPESNYCLK  NDL 
SDDHVTAG-LLTMPLPMILGHEAAGVVESTGEGVTSLKPGDK  VIPLFVPQCGECMPCLKSNGNLCIR  NDL 
 
GNPRGTLQDG-TRR  FTCR GKPIHHFLGTSTFSQYTVVDENAVAK  IDAASPLEK  VCLIGCGFSTGYGSAVNVAK  
GS-PSGLMADGTSR  FTCK GKDIHHFIGTSTFTEYTVVHETAVAR  IDAAAPLEK  VCLIGCGFSTGYGAAVKDAK  
 
VTPGSTCAVFGLGGVGLSAVMGCK  AAGAAR  IIAVDINK  DK  FAK  AK  ELGATECINPQDYK   
VEPGSTCAVFGLGGVGLSTIMGCK    AAGASR     IIGIDINK  DK  FAK  AK  ELGATECINPLDCK   
 
 
Figure 5  Sequence alignment of the human and alligator ADH protein. 
Partial protein amino acids sequences for alcohol dehydrogenase are aligned above from human and alligator 
(75% identity). Regions alignable by error-tolerant sequence tags between the two sequences are highlighted in 
gray. These regions are theoretical tryptic peptides over six amino acids in length with ≥ three conserved amino 
acids from the N-terminus or ≥ four conserved amino acids from the C-terminus. Tryptic cleavage sites 
designated above are shared between both sequences. Tryptic cleavage sites not at the same point on the 
sequences are not designated by spaces; sites do not occur in the gray regions. Accession numbers: human, 
P00325; alligator, AAB28120. The sequences were aligned using the Clustal X program.  
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Database Search1: Full tag   (815.47)ELD(1172.61)
Database Search2, One error  (815.47)E?D(1172.61),
(815.47)EL?(1172.61),(815.47)?LD(1172.61)
Database Search3: Regions 1,2        ELD(1172.61)
Database Search4: Regions 2,3(815.47)ELD
MultiTag Sorts and Calculates the Significance of 
Multiple Error-Tolerant Sequence Tag Alignments
Combine Search Results and Submit to MultiTag1.
2.
3.
4.
100 400 800 1200
13
26
Intensity, C
ounts
707.88
815.47 944.50
1172.61
[M+2H]2+  
1057.54 
MS/MS
m/z
E       D      L
Tag Region:        3                                        2                1
0
 
Figure 6  MultiTag method schematic.   
The MT approach consists of constructing sequence tags from peptide tandem mass spectra, error-tolerant 
database searches, and sorting and calculation of the significance of multiple error-tolerant sequence tag 
alignments by the MT software. Panel 1. shows a tandem mass spectrum of a low abundance peptide with an 
overlaid sequence tag. Panel 2. shows one complete and three error-tolerant sequence tag database searches, 
which is done for each MS/MS spectrum and corresponding sequence tag. Panel 3. shows the combined list of 
search results (most of the 8000 entry list is not shown) from all spectra and all searches in the analysis of a 
single sample; “Tag Mass” column indicating the tag’s parent mass followed by an “NC” for search results 
with complete tags, an “N” for searches with tag regions 1 and 2, an “E” for searches with tags with one amino 
acid error, or a “C” for searches with tag regions 2 and 3; “Sequence” column is the retrieved sequence found 
from the database search; “Mass” column indicates the protein’s total mass in kDa from which the peptide 
originated; “DB Accession” the proteins accession number; “Protein name”; “Species”. Panel 4. shows the MT 
output; “Tag Mass” column lists the tag-search code for the tags aligned; “Sequence” lists all of the full peptide 
sequences error-tolerantly aligned; “Mass”—“Species” same as Panel 3; “E-values” for the probability of the 
alignment of the group of sorted sequence tags.  
  
2.1.3 Calculation of E-values  
(in collaboration with Professor Shamil Sunyaev) 
The major problem of DB searching with multiple sequence tags is the need to identify hits 
corresponding to truly homologous proteins in the large pool of randomly matching proteins 
produced of multiple degenerate searches, and therefore the evaluation of statistical 
significance of hits is ultimately required. The classic way to interpret the results of a DB 
search in the statistical framework is to assign an E-value to each hit resulting from a 
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search. E-values corresponding to a hit represent the expected number of better or equally 
good matches found in a DB at random. In the case of the MT search, a DB search hit is a 
protein sequence, which matches some sequence tags in a degenerate or a non-degenerate 
manner. E-values here give the expected number of sequences from a random DB, which 
would match the same combination of tags in the same way or even more specific (less 
likely) combination of tags in a more specific way. In order to compute E-values, the 
probability that a given tag with a given type of degeneracy would match a random amino 
acid sequence had to be determined. The probability that a given combination of tags would 
match a random sequence can then be computed as a product of the probabilities 
corresponding to individual matches. Further, the probability that any possible more 
specific (less likely) combination of tags than a given combination would match a random 
sequence has to be determined. Finally, the E-value would be given by multiplication of the 
latter probability to the total number of DB sequences. Below the detailed consideration of 
each of those steps is presented.  
Let us consider a sequence tag, which is represented by an N-terminal mass mN, 
three amino acids a1, a2, a3 and C-terminal mass mC. The probability that a random tryptic 
peptide would match this tag in a non-degenerate manner would be given as a product of 
three following probabilities. First, the probability that the random tryptic peptide has an N-
terminal fragment of any length, whose mass lies in the interval (mN-∆m, mN+∆m), where 
∆m is mass tolerance of the instrument. Second, the probability that this fragment of 
random peptide has amino acids a1, a2 and a3. This is simply given by the product 
f(a1)f(a2)f(a3), where f(ai) denotes frequency of amino acid ai. And third, the probability that 
the mass of the random peptide fragment between these amino acids and the C-terminus 
would be between mC-∆m and mC+∆m.  
In order to derive probabilities corresponding to mN and mC one would regard the 
mass of a random tryptic peptide being a result of a random process. We imagine that the 
sequence of the random tryptic peptide was constructed by a random generator, which 
consequently generates amino acids, one at a time, and the probability that next coming 
amino acid will be ai is given by its frequency f(ai).  Obviously, at each moment of time the 
generator can produce a trypsin cleavage site (K or R residue) with the probability 
q=f(K)+f(R) and thus stops the process. The mass M of the random tryptic peptide can be 
regarded as an accumulated sum of masses of randomly generated amino acids: 
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...321 +++= MMMM      (1) 
 
In probability theory, random values represented as successive sums of positive 
identically distributed variables as in equation (1) are called a renewal process[89]. 
Obviously masses of randomly generated amino acids obey the probability distribution 
determined by amino acid frequencies, so that the probability p(m) that the random mass 
would be exactly m is given by combined frequency of amino acids of mass m. Then, the 
distribution of the mass accumulated after n+1 step, i.e. the probability that the peptide 
fragment of length n+1 would have its mass smaller than t can be computed via successive 
convolutions: 
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Summation here is carried over all values of amino acid masses. Multiplication to (1-q) is 
needed to take into account that the process survived the n+1-th step, i.e. the tryptic peptide 
has more amino acids than n+1.  
The distribution of the total mass of the tryptic peptide, i.e. the probability that the 
peptide’s total mass would not exceed t is given by allowing for all possible lengths of the 
peptide: 
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Which implies that the probability that the peptide’s mass would be in the interval from m-
∆m to m+∆m is 
 
 ( ) ( )mmFmmFmmP ∆−−∆+=∆ ),(     (4) 
 
 Although not intuitively obvious, this formula holds both for the whole mass of the 
peptide and for any of its fragments between a fixed amino acid position and the cleavage 
site. Indeed, if we further consider our analogy with the renewal process, it will retain its 
properties regardless of the point we consider the process started (the process has no 
memory). Therefore, after the position of the sequence tag on the peptide sequence is fixed 
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through matching one mass and the short sequence stretch, the probability that the second 
mass would also match is given by equation (4). 
 Now consider matching of the sequence tag as a sequence of three consecutive 
independent events, namely match of the first mass, match of the short sequence stretch and 
the following match of the second mass. Although, the consideration is obviously 
symmetric with regard to N- and C-termini of the peptide, without loss of generality, we 
would assume that the N-terminal mass is the first mass to match. The probability that the 
mass of any N-terminal fragment of the peptide would be in the interval (mN-∆m, mN+∆m) 
is given by: 
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A multiplier 1/q was introduced because in this case the process survives the step with this 
mass, i.e. all peptides with arbitrary lengths with N-terminal parts matching the mass would 
satisfy the condition. We note that the equation 5 holds only if mass tolerance of the 
instrument is lower than any of amino acid masses, otherwise it corresponds to the 
expectation and not to the probability. 
 Since the probability of the non-degenerate match of the sequence tag would be a 
product of probabilities of the N-terminal mass match (which importantly fixes the position 
of the tag along the peptide), sequence stretch match and the C-terminal mass match it will 
be expressed as: 
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Additional multiplier 1/(1-q) simply reflects the fact that we do not consider zero length 
tryptic peptides, allowed by the model if the cleavage site comes at the first step. Therefore, 
we work only with 1/(1-q) fraction of realistic peptides. 
  Examples of probabilities for degenerate matches are given by: 
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As the next step, we compute the probability that a random protein sequence containing K 
tryptic peptides would match multiple sequence tags, taking into account the tags being 
matched and the type of degeneracy of the match. For instance, if we had three sequence 
tags and the random sequence matched simultaneously sequence tag 1 with an error in the 
N-terminal mass, sequence tag 2 with an error in the C-terminal mass and sequence tag 3 
with a mismatch at the second identified amino acid, the probability of the event would be 
given by: 
          (8) 
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This example shows how to compute the probability that a random amino acid 
protein sequence would match an arbitrary combination of sequence tags. 
In order to calculate E-values, we should first compute the probability that any 
combination of tags would match a random amino acid sequence, which is equally or more 
specific than the combination observed. In other words, we will need to sum up 
probabilities (eq. 8) of all possible matches, which do not exceed the probability of the 
actual DB hit. It is definitely too demanding computationally to directly enumerate all less 
likely combinations of tags. However, it appears to be much easier to enumerate all 
combinations, which are, in opposite, more likely to happen because they mostly involve 
matches with a very few tags. Therefore, we compute the probability that a random 
sequence would produce a less specific match than the actual hit (taking care of possible 
statistical dependence of various combinations of tags) and subtract the result from 1. E-
value is then computed by multiplying the result to the DB size.  
A series of computational simulations have been carried out to validate the 
computation of E-values described above.  
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 Software implementation of MT uses pre-computed distribution function F(t). The 
software imports sequence tags in the conventional format (mc)a1…an(mn)[86] and peptide 
mass, and computes probabilities for each tag to match a random tryptic peptide. Further, 
the software imports a full list of hits produced by multiple degenerate and non-degenerate 
sequence tag searches and identifies hits corresponding to the same protein. For each hit 
MT first computes the probability of the match (similarly to equation 8). Then, it identifies 
all tag combinations giving the same or higher probability, and based on this information, 
assigns E-value to the hit.  At the final step, MT sorts all hits according to E-values. 
 
2.1.4 Specificity, Performance, and Limitations of Error-Tolerant MultiTag Searching 
MT aligns multiple partial and/or complete sequence tags to increase the coverage of a DB 
sequence from available MS/MS data to raise the significance and lower the E-value of 
identifications. Sequence tags were used from the identification of DNA polymerase (Table 
1) to perform alignments with MT to demonstrate factors that contribute to final E-values 
(Table 2). High E-values are given for “poor” quality tags that have short mass lengths for 
tag regions 1 and 3, and designate common amino acids with a high frequency in proteins, 
i.e. Leucine, “L.” Lower E-values are given for uncommon amino acids such as 
Tryptophan, “W,” or for tags with more amino acids in the sequence stretch.  The 
probability that a combination of partial sequence tags will match a single DB entry is lower 
than if an individual tag is matched, with an increasing significance as more partial 
sequence tags are aligned. Two partial sequence tags were found to be not significant 
enough for a confident identification in some cases, depending on the character of the tags. 
However, the alignment of three or more partial sequence tags lowers E-values to the range 
of 1E-6-1E-9 when mass accuracies are sufficiently high, enabling confident protein 
identification. Sequence tags assembled with narrower mass tolerance increase the 
specificity of DB searching and lower the E-values of hits.  As in case of conventional DB 
sequence-similarity searches, specificity of the MT search decreases with the growing size 
of the DB.  
An intrinsic problem to all statistical approaches to homology searches relying on 
average amino acid frequencies is posed by low complexity regions and other proteins 
and/or protein regions with amino acid frequencies, which strongly deviate from the DB 
average[90]. If a MT identification results in a peptide from a low complexity region or in a 
peptide of obviously special amino acid composition, these identifications have to be 
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interpreted with caution, since the underlying statistical model does not account for bias in 
amino acid composition. 
An advantage of MT over MS BLAST, besides its ability to represent noisy and low 
intensity spectra, is that peptide sequences retrieved by sequence tag searches can be 
overlaid on fragment ion spectra allowing one to determine whether the retrieved sequence 
is the correct sequence; this is less direct with MS BLAST. Even though relatively weak 
matches can be evaluated in this way, the MT approach is suited for a high-throughput 
setting without the need to go back to the original spectra to evaluate the identifications. 
The determination of the significance of sequence tags by the MT statistics takes the place 
of retrospective manual data evaluation. 
MT, as well as any sequence-similarity searching method, is prone to errors if the 
analyzed protein contains low complexity sequence regions, i.e. collagen, Glycine-rich cell 
wall proteins, and silk proteins. Because MT only recognizes a few central amino acids 
accurately, it would be possible that multiple sequence tags to different regions of the same 
proteins could not be distinguished, thus diminishing the overall score.  
 
2.1.5 Identification of Proteins from Xenopus laevis by MultiTag Searching 
The MT approach was applied to the identification of proteins isolated from the African 
clawed frog Xenopus laevis. In-gel digests of Xenopus proteins were analyzed by PMF and 
NanoESI-MS/MS. Sequence-similarity searching methods were applied for protein 
identification because Mascot DB searching with peptide mass fingerprints and with lists of 
fragment masses derived from uninterpreted tandem mass spectra were unable to identify 
proteins by stringent matching. Two methods of sequence-similarity searching were applied 
in parallel to the same set of MS/MS data. Peptide sequence proposals obtained by 
automated de novo interpretation of tandem mass spectra were submitted to MS BLAST 
searching. In parallel, peptide sequence tags were assembled via partial manual 
interpretation of spectra (Figure 4), followed by error-tolerant DB searching and sorting and 
evaluating the results by MT, as described above (Table 1). From five attempted unknown 
proteins, MS BLAST identified three, however all five were identified by MT. Importantly, 
in three cases both MT and MS BLAST identified homologous sequences from the same 
organism or from different species, providing an independent validation of the MT 
approach.  
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Table 1 Sequence Tags used in the Identification of Xenopus Proteins by MultiTag. 
 
MultiTag Protein Identifications Tags Submitted Mass Matching Tags MS BLAST Identifications Alignments 
Isoleucyl-tRNA Synthetase  (371.24)VTY(734.42)       846.5 (371.24)VTY(734.42) No identification None 
Human P41252 (637.34)VL(849.49)         935.51     
E-value: 2.73E-5 (587.36)VSQ(901.52)      1047.55 (587.36)VSQ   
 (488.34)LEL(843.55)        1099.56     
E-value:  First False Positive:  0.15 (602.42)EQ(859.53)        1134.64     
 (979.62)DVS(1280.74)    1408.76 DVS(1280.74)   
 (1166.60)DLL(1507.80)    1619.81     
 (1363.59)VV(1561.73)     1918.98     
  (985.50)NT(1200.59)        2329.25       
Glutamyl-Prolyl-tRNA Synthetase  (492.31)TY(756.42)  902.49 (492.31)TY No identification None 
Human XP_001958 (559.31)QAS(845.44)  942.03     
E-value: 7.14E-7 (559.33)QVS(873.49)  971.57     
 (545.27)LWT(945.48)  1058.58     
E-value:  First False Positive:  0.52 (705.35)LE(947.47)  1192.62     
 (626.40)LLDE(1096.64)  1357.67     
 (1177.60)LLA(1474.81)  1544.87 (1177.60)LLA(1474.81)   
 (926.54)FSLTDT(1590.84)  1688.94     
  (561.34)AVEP(957.54)  1711.92 (561.34)AVEP     
DNA Polymerase Delta (401.30)PVP(694.48)    750.5   DNA Polymerase Delta  
Human S35455 (486.38)SE(702.45)      772.49   Human P28340   
E-value: 8.14E-7 (441.21)PF(685.33)      797.42     
 (456.31)FT(704.42)      816.48 (456.31)?T(704.42)  LTFALPR 
E-value:  First False Positive:  0.35 (345.25)QEL(715.43)       827.49 (345.25)QEL(715.43)   
 (385.28)LY(661.42)      846.49 (385.28)LY(661.42)  DAYLPLR 
 (421.29)EAW(807.44)   877.48     
 (583.32)LGG(810.44)   908.5 LGG(810.44)  VGGLFAFAK 
 (543.30)LNL(883.51)    995.6     
 (470.29)FVL(829.51)   1071.58     
 (533.32)LPE(872.50)   1131.65 LPE(872.50)   
  (889.45)QS(1104.54)    1190.56       
Hsp70/Hsp90 Organizing Protein (494.26)DSLL(922.48) 992.53   Stress-Induced   
Chinese Hamster AAB94760 (408.23)FQLA(867.48) 995.51   Phosphoprotein STI1  
E-value: 7.82E-9 (550.27)ELL(905.48) 1017.56 (550.27)E?L(905.48) Xenopus AAM77586  
 (585.40)GVDF(1003.59) 1115.67 (585.40)G?DF(1003.59)  LFDVGLLALR  
E-value:  First False Positive:  0.59 (674.38)NGAS(1003.52) 1186.65 NGAS(1003.52)  ALSAGNLD 
 (416.24)ELL(771.45) 1350.72 (416.24)ELL   
  (856.51)NLYA(1317.73) 1415.8     VAYLNPD 
Heat Shock Protein 90-beta (385.26)FLL(758.50) 828.53 (385.26)FLL(758.50) Heat Shock Protein 90-beta ALLFLPR 
Zebrafish NP_571385 (567.28)Y(730.35) 876.43 (567.28)Y(730.35) Salmon AF135117(Nucleotide) FYDGFTK 
E-value: 4.35E-9 (401.29)ES(617.37) 729.45 (401.29)ES(617.37)  LSELLR  
 (708.37)NAV(992.52) 1234.64 (708.37)N?V(992.52)   
E-value:  First False Positive:  0.0051 (716.34)NLL(1056.55) 1241.69 NLL(1056.55)   
      LTPDQPVV 
 
For each sample, sequence tags were constructed from multiple MS/MS spectra from the analysis of a single 
in-gel digest (“Tags Submitted”) and error-tolerantly searched against a protein database (resulting list of 
entries not shown). The “Mass” column contains the corresponding complete mass for each sequence tag. 
Results were sorted by MT. Groups of matching partial sequence tags resulted (“Matching Tags”). E-values for 
the group of partial sequence tags were calculated by the MT software (first column in Bold). The final 
MultiTag report gave a list of database entries with diminishing E-values (data not shown). E-values are cited 
(column 1, “First False Positive”) for the first database entry in the list to not correspond by annotated function 
(i.e. HSP 90) to the most significant hit. Protein identifications made by MS BLAST are found in the column 
“MS BLAST Identifications” and peptide sequences aligned are in “Alignments.”  
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This data demonstrates that MT can outperform the more generic sequence-
similarity searching tool—MS BLAST—when de novo sequence prediction is unable to 
produce meaningful peptide sequences from noisy or low intensity spectra. On the other 
hand, MT successfully identified the proteins because sequence tags are easily assembled 
from tandem mass spectra where complete amino acid sequence prediction is impossible 
(Figure 4). The results suggest that three and more error-tolerantly matching sequence tags 
may unequivocally identify a homologous protein (Table 2), despite none of the sequenced 
peptides exactly matched the corresponding sequence from a DB entry and sequence 
stretches of less than four amino acid residues were determined. Both MT and MS BLAST 
were able to identify the proteins not identified by Mascot because they could tolerate 
amino acid substitutions, resulting in an offset of the peptide’s total mass. 
 
2.1.6 Homologue Identification Specificity of MultiTag Searching 
By its algorithm, MT is a less generic sequence-similarity searching tool, compared to MS 
BLAST and FASTS since it requires identical (although short) stretches of peptide 
sequence for protein identification. We roughly estimated the scope of MT identification 
from the bottom, assuming the most unfavorable model when identical amino acids between 
proteins are distributed uniformly along the sequence. According to our experience and 
table 2, three partial matches normally give a statistically significant match. We have 
estimated the chance to obtain three partial matches and its dependence on the overall 
identity of the complete query sequence and the DB sequence. A very simple calculation 
assumes that the probability that a single amino acid would match between the query and 
the DB sequence is equal to the overall sequence identity and is independent of the 
sequence region and amino acid type. Assuming further a query of 10 identical tags we 
estimated that the MT method is able to identify almost all homologues at the level of 80% 
sequence identity, 75% of homologues at the level of 75% sequence identity, but only about 
45% of homologues at the level of 70% sequence identity. Obviously, MT cannot achieve 
the specificity of the methods using the knowledge of longer sequence parts. According to 
simulations results, sequence based methods like MS BLAST and FASTS are able to detect 
about 50% of homologous sequences at the sequence identity level of ~50%[61]. According 
to our lower limit estimate, MT would require 71% sequence identity (in reality less) to 
reach the same efficiency of identifications. However, simulations with MS BLAST and 
FASTS were performed assuming all sequence predictions are correct, which is rarely the 
case. Therefore, the advantage of using MT is the ability to identify sequence similarities at 
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the reasonable level with high robustness with respect to the quality of the raw data and 
independently of the quality of automated or manual de novo sequence prediction 
techniques. 
 
 
 
 
Table 2 MultiTag E-values are Dependent on Amino Acids in Tag, Number of Tags, Mass Accuracy, and Database Size. 
          E-values PredCount E-values
  Mass Sequence Tags in the identification of DNA Polymerase 1.0 Da* 0.5 Da* 0.1 Da* 0.1 Da* 
1,600,000 
 DB Entries** 
200,000  
DB Entries** 
1 816.48 (456.31)?T(704.42)      6.06E+03     2.73E+03 2.56E+03 1.76E+02 5.11E+03 6.39E+02
2 827.49 (345.25)QEL(715.43)    1.96E+02     8.83E+01 8.34E+01 1.23 1.67E+02 2.09E+01
3 846.49 (385.28)LY(661.42)      2.61E+02     1.30E+02 1.29E+02 2.66 2.58E+02 3.22E+01
4 908.5 LGG(810.44)   8.36E+03     6.53E+03 6.92E+03 9.81E+02 1.38E+04 1.73E+03
5  1131.7 LPE(872.50)   1.73E+03     1.01E+03 9.52E+02 7.06E+01 1.90E+03 2.38E+02
6 LGG(810.44) + LPE(872.50)   5.08E+01 2.71E+01 2.51E+01 9.23E-02 5.16E+01  6.45E+00
7 LGG(810.44) + LPE(872.50) + (456.31)?T(704.42)    1.24E-01 3.09E-02 2.86E-02 2.17E-05 5.72E-02  7.15E-03
8 LGG(810.44) + LPE(872.50) + (456.31)?T(704.42) + (385.28)LY(661.42)     1.97E-05 3.23E-06 3.01E-06 7.68E-11 6.02E-06  7.53E-07
9 LGG(810.44) + LPE(872.50) + (456.31)?T(704.42) + (385.28)LY(661.42) + (345.25)QEL(715.43) 1.49E-06 8.60E-07 8.14E-07 1.26E-16 1.63E-06  2.03E-07
10 LGG(810.44) + LPE(872.50) + (456.31)?T(704.42) + (385.28)LY(661.42) + (345.25)QEL(715.43) 3.64E-09 4.17E-09 3.55E-09 1.31E-16 7.11E-09  8.88E-10
 
The E-value in Bold is shown in Table 1. In the calculation ofE-values for row 9, all tags submitted were included from Table 1. In row 10, 
only the tags that matched the database entry were included in the list of tags submitted for MT calculations (reduced query length. 800,000 
and 200,000 database entries correspond approximately to the NCBI Nonredundant (nrdb) and SwissProt protein databases, respectively.   
“Mass” in column 2 indicates the full length of the peptide corresponding to the sequence tag in column 3. *800,000 database entries, **Mass 
Accuracy of 0.1 Da. 
2.1.7 Enhanced Error-tolerant EST Database Searching by Tandem Mass 
Spectrometry and MultiTag Software 
In general, there are a number of difficulties when searching EST databases with MS data. 
First of all, ESTs represent nucleotide sequences, whereas amino acid polymers are 
analyzed by MS. This however can easily be overcome by these sequences inherent 
colinearity, which allows the translation of either EST sequences, or amino acid queries, in 
six frames into theoretical amino acid sequence, or nucleotide sequence, respectively, for 
DB searching. Secondly, ESTs are generally short sequences, translating into ~150 amino 
acids of polypeptide sequence each. Therefore, many large proteins (i.e. 80-300kD) will 
only be represented by a short sequence stretch, and we would expect many analyzed 
peptides to be left unaligned. This may be overcome by assembling multiple EST sequences 
into cDNA clones of the expressed genes, potentially covering the length of the expressed 
protein. Thirdly, EST sequences are generated by single-pass sequencing of cDNA clones 
(generated from mRNAs), which would likely result in multiple errors. Thus, even in 
searching sequences from the organism of origin (not cross-species), an error-tolerant 
method such as MT would be expected to be more sensitive than a method that demanded 
exact matching because more partial peptide sequences could be aligned to produce a higher 
coverage and more significant alignment.  
Protein identification by the interpretation of tandem mass spectra with sequence 
tags and EST DB searching has relied upon the searching of databases one sequence tag 
(and thus one spectrum) at a time. Since the sequence tag is only a partial interpretation of a 
spectrum, multiple degenerate DB sequences are recognized in most searches, matching 
entries from many different species and proteins with varying molecular weights (when a 
tag is searched error-tolerantly, even more entries are retrieved). Therefore, these retrieved 
sequences must be manually inspected and the false positives must be discriminated against 
in a time-consuming operation. The MT method overcomes this problem by correlating 
search results from multiple spectra to determine the most probable protein identification(s). 
MT sorts DB search results (including combined results from full and partial tags) by their 
statistical significance and assigns an E value for every set of alignments, thus indicating 
alignments otherwise missed and greatly facilitating interpretation of sequence tag-driven 
DB search results. Since there is often an abundance of EST sequence data in silico, the 
utilization of these sequences, either as independent resources or by applying alternate DB 
searching strategies simultaneously (reviewed in section 2.5.3) could greatly facilitate 
protein identification.  
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To test the specificity of MT versus Mascot in EST DB searching, a model dataset 
was used that was generated in a screen of microtubule-associated proteins from Xenopus 
laevis (see section 2.2). Gel separated Xenopus proteins were analyzed by nanoelectrospray 
M/MS and identified by protein DB searching using multiple techniques, which gave 
significant matches for a single protein often with Mascot, MS BLAST, and MT (and 
corresponding greater sequence coverage with the later methods generally).  
To facilitate the DB searching process with sequence tags, a script has been 
developed (in collaboration with Applied Biosystems, Foster City, CA, USA) for automated 
error-tolerant searching to generate unsorted search results for submission to the previously 
described MT software[91]. This script “MTSearch” was developed specifically for 
BioAnalyst QS (Applied Biosystems, CA) to automatically search a list of complete and 
error-tolerant sequence tags against a DB and compile the results in an unsorted list. The 
previously described MT software subsequently sorts search results by the statistical 
significance of combinations of multiple tags and individual tags. The results of MTSearch 
can be directly submitted to the MT statistics software (Figure 7).  
A modification was made to MT for EST DB searching. MT relies upon an 
expected number of peptides per protein sequence, which was previously averaged at 41 
peptides per protein for protein DB searching. The average protein length in a non-
redundant DB was previously determined to be 492 amino acids (corresponding to ~60kD). 
The average length of a tryptic peptides was designated at 12 amino acids, setting the 
average number of tryptic peptides per DB entry at 41. Since EST DB sequences are 
shorter, we would expect fewer peptides possible from each entry; therefore the parameter 
designating the number of peptides expected per DB entry was made adjustable to account 
for differences in length. Secondly, MT relies upon a designated size of the DB searched for 
producing a probability of a random match. This is straightforward with protein DB 
searches because this is a designated number of DB entries. For EST DB searching, all 
nucleotide sequences or the query must be translated in six frames, generating additional 
erroneous hypothetical sequence; only one frame is the correct translation; the number of 
entries were multiplied by 6 to account for this degeneracy.  
A set of DB searches was performed using Mascot, relying upon its own statistics, 
and MT, relying upon E values for the determination of true versus false positives, as a trial 
to judge the sensitivity of MT. Peak lists with corresponding intensities were generated 
automatically from tandem mass spectra of protein digests and were submitted to Mascot 
for DB searching. Sequence tags were constructed by manual interpretation from the same 
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set of tandem mass spectra; averaging ~9 sequence tags per protein digest, which required 
~4 minutes of spectrum interpretation per tag. Sequence tags were used for DB searching 
and the results were analyzed by MT. EST sequences from Xenopus laevis[92] were used as 
reference by both methods for protein identification. In general, MT can make direct 
identifications or cross-species identifications.  
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Figure 7  Integrated MultiTag database searching scheme 
 
To interpret peptide tandem mass spectra with MT for DB searching: 1. Construct tags and list in text file; 2. 
Run DB search script; 3. Submit search results to MT software for sorting by probabilities. MT search script is 
written for Applied Biosystems Bioanalyst QS software. MT software was modified for EST DB searching as 
described above.  
 
 
The MT software reports a “Predicted Count” (PredCount) value and an E value for 
every alignment. The employed statistical model implies that the first species-specific false 
positive should be detected at an E value of approximately 1. The second false positive 
should have an E value of 2, and the third false positive an E value of 3, etc. Because of the 
imperfections of the statistical model, E values less than 0.1 generally indicate true matches, 
with more significant matches having lower E values. PredCount values reflect the 
specificity of matches; however, PredCount does not reflect the expected number of false-
positives when the entire query is searched against a DB. Contrary to E values, PredCount 
values very weakly depend on the number of tags in a query, and low PredCount values 
serve as a further statistical indicator of true matches when E values are high due to large 
queries where few sequence are aligned.   
From the model data set, Mascot was able to recognize 49 peptides with optimized 
settings, making 20 identifications (Table 3). From the same dataset, MT was able to 
recognize 87 peptides and produced 31 identifications, which included all of the Mascot 
  
                                                                                                                                         45
identifications. Whereas many identifications are statistically at the borderline by Mascot, 
MT was able to increase the coverage of these alignments by error-tolerant matching of 
partial peptides to provide more evidence for a positive identification in 12 cases. 
Furthermore, MT was able to make significant alignments in 11 cases where Mascot could 
not. 
Where MT was able to make a significant alignment and Mascot produced no 
significant matches, the top five Mascot hits were inspected to see if the same protein had 
been nonconfidently detected. Since it is possible that MT may recognize one specific EST 
with a query and Mascot may recognize a different EST corresponding to the same cDNA 
sequence, these top hits were carefully inspected to find alternate ESTs matching the same 
protein sequence. Where MT was unable to make a significant alignment, the top five MT 
hits were manually inspected by overlaying the retrieved peptide sequence “on the 
spectrum” using BioAnalyst QS, and comparing the observed fragment ions with 
theoretically calculated fragment ions (at a precision of 0.001 m/z), taking into 
consideration abundant a, b and y series ions, and immonium ions. In this manner, MT was 
able to detect 6 additional matches; 3 of these 6 were not in the Mascot top 5 hits (data not 
shown). This suggests that the MT method can also retrieve true matches that are not 
statistically significant; single hits below threshold should be manually inspected if no other 
alignments are made.  
From this data, MT proves to be a sensitive method for EST DB searching, both 
because more identifications were made than the conventional software and more peptides 
were identified in total, resulting in a higher coverage of proteins. 
The MT approach for enhanced EST DB searching balances the specificity and 
sensitivity of mass spectra interpretation using sequence tags with the sequence tags’ 
inherent degeneracy in DB searching.  In cases where EST sequences would be assembled 
as cDNA clones, we would expect even higher coverage because often MT hit multiple tags 
for different EST sequences of the same cDNA sequence (data not shown). Furthermore, 
MT also would be expected to have fewer false positives because there is no cutoff 
threshold (like conventional softwares), and all borderline hits must be discriminated 
against by manual inspection. However, MT does require manual spectrum and data 
interpretation that is not required by conventional softwares, and because of the 
effectiveness of the conventional softwares, MT would be applied most efficiently in cases 
where other methods fail to make an identification, or where they have recognized certain 
proteins only on the borderline of their scoring thresholds.   
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Table 3 EST database searching: Mascot vs. MultiTag  
 
MW Mascot EST_others  P. MultiTag EST_others Tags Query PredCount E value  
175 Glutamyl-propyl-tRNA syn., 12748494 1 Glutamyl-propyl-tRNA syn., 14989013  2 11 2.70E-13 2.10E-04 
175 Glutamyl-propyl-tRNA syn., 14989013  1 Glutamyl-propyl-tRNA syn., 17398490 2 & 1 9 1.10E-12 1.10E-06 
165 †   Glutamyl-propyl-tRNA syn., 24091165 2 9 1.70E-08 5.70E-06 
165 †   Glutamyl-propyl-tRNA syn., 12746970 1 4 5.07E-04 3.81E-03 
160 Hyaluronan mediated receptor, 13252946 1 Hyaluronan mediated receptor, 13252946 2 9 5.82E-09 1.42E-04 
155 †   Isoleucyl-tRNA synthetase, 24090398 2 & 1 9 2.31E-13 7.39E-08 
150 †   Leucyl-tRNA synthetase, 21870435  2 12 3.36E-06 1.57E-03 
150 †   Leucyl-tRNA synthetase, 21870435 2 6 3.81E-06 3.36E-04 
122 Kinesin heavy chain, 17418741 3 Kinesin heavy chain, 17418741 2 9 1.42E-08 5.37E-06 
122 Kinesin heavy chain, 12480559 2 Kinesin heavy chain, 12480559 2 & 1 7 6.79E-12 1.94E-08 
118 Kinesin heavy chain, 17418741 2 Kinesin heavy chain, 17418741 3 10 1.27E-16 3.13E-08 
  Kinesin heavy chain, 12480559 2 Kinesin heavy chain, 12480559 3 10 8.96E-16 3.13E-08 
100 Elongation factor-2, 11787464  2 Elongation factor-2, 21875348 2 6 3.73E-06 1.27E-02 
90 Heat shock protein, 10065828 2 Heat shock protein 90-beta, 21873865 3 & 1 13 1.12E-17 8.96E-07 
  Glutaminyl-tRNA synthetase, 7699102 2 Glutaminyl-tRNA synthetase, 7393733 3 13 1.57E-14 8.96E-07 
85 †   Cytoplasmic dynein inter. chain, 24082627 3 9 1.12E-17 4.48E-06 
70 Heat shock cognate-70, 21384290 5 Heat shock cognate, 24087000 2 & 1 7 5.00E-15 3.43E-08 
68 Lysyl-tRNA synthetase, 17580417 2 Lysyl-tRNA synthetase, 24097853 2 4 5.00E-06 3.21E-04 
68 Lysyl-tRNA synthetase, 12473885 3 Lysyl-tRNA synthetase, 12473885 3 9 4.03E-14 1.12E-07 
68 HSP70/HSP90 org. protein, 17395146 2 HSP70/HSP90 org. protein, 21874237 2 & 1 7 3.73E-15 6.19E-09 
52 Alpha-tublin, 12471404 2 Alpha-tublin, 21863612 2 16 7.46E-09 3.88E-03 
  Formiminotrans. cyclode., 17413939 1 Formiminotrans. cyclode., 12471624 2 16 5.67E-10 3.88E-03 
50 Alpha-tublin, 12471404  4 Alpha-tublin, 24097682 3 & 1 18 9.70E-20 2.01E-06 
  Beta-tublin, 17425087  2 Beta-tublin, 24093819 3 18 3.66E-15 2.01E-06 
50 Elongation factor-1 gamma, 17414578 6 Elongation Factor-1 gamma, 17527452 5 18 3.58E-25 3.58E-06 
  Elongation factor-1 alpha, 10063988    4 Elongation factor-1 alpha, 21071694 3 18 3.28E-12 3.58E-06 
36 Elongation factor-1 delta, 17397886    2 Elongation factor-1 delta, 24082682 4 5 2.24E-23 1.27E-09 
34 60S Ribosomal Protein L5B, 14181865 1 60S Ribosomal Protein L5B, 14181865 1 & 1 5 1.12E-09 3.36E-08 
30 40S Ribosomal protein, 14185581 1 40S Ribosomal protein S3, 24085095 2 6 2.54E-08 4.33E-06 
28 Elongation factor 1-beta, 17398022  2 Elongation factor 1-beta, 24091513 3 & 2 7 5.67E-31 2.24E-08 
28 †   Elongation Factor 1-beta, 21088085 4 5 6.57E-19 5.22E-09 
Total Peptide hits = 49  87    
Identifications =  20  31    
 
Two similar sets of purified proteins contributed to the identifications above. Peptides = no. of peptides 
matched to any single DB entry; Tags = no. of complete and partial tags matching any single EST sequence, X 
& Y (complete tags & partial tags, respectfully); Tags in Query = no. of tags submitted in query; † not in top 5 
hits; Mascot hits below threshold score in top 5 are in italics; apparent molecular weights (MW) in KiloDaltons 
for corresponding gel bands. 
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2.1.8 The Broader Significance of MultiTag  
The MT approach addresses an issue of growing prominence among the proteomics 
community: universal statistical evaluation of protein identifications[93,94]. It is a goal of 
the proteomics community to set a threshold for protein identifications in high throughput 
settings, so that a protein confidently identified in one laboratory will be confidently 
identified by a similar method in another institution. Consequently, the statistics of MT 
takes a step in this direction and determines the significance of sequence tag alignments in a 
manner that can be adopted as a universal standard evaluation of sequence tag 
identifications without the need for retrospective inspection. As the MT approach could be 
applied to the mining of genomic databases, the statistics will require alteration due to the 
size and nature of these searches. The independent statistics of MT lends the method to a 
wide application and to high throughput settings. 
With further software developments it will be possible to completely automate the 
MT method for high throughput proteomics of organisms with unsequenced genomes or the 
analysis of highly modified proteins from organisms with sequenced genomes. Currently 
the ability to call sequence tags automatically is available, and a scripted interfaced can be 
written to create lists of sequence tags for spectra acquired from a complete LC-MS/MS 
run. A corresponding scripted interface for DB searching has been written that can produce 
a complete list of encoded retrieved DB entries for submission to MT for sorting and 
significance calculation (see section 2.1.7). 
Following developments in automation, MT will be a good complementary method 
to de novo sequence prediction based methods like MS BLAST and FASTS for sequence-
similarity protein identification in high throughput settings, thus expanding the repertoire of 
spectra interpretation and DB mining tools in the hands of mass spectrometrists. As 
sequence-similarity methods develop, the proteomes of organisms with unsequenced 
genomes will become more amenable for characterization, contributing to the development 
of medicine, agriculture, and the biological sciences in general.   
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2.2 Xenopus laevis Functional Proteomics  
2.2.1 Xenopus laevis as a Model System 
Functional proteomics couples purification of multiprotein complexes, organelles, or 
specific macromolecular structures with identification of protein components by MS, and 
provides an effective methodology for the elucidation of the molecular architecture of 
cells[95,96]. An important model organism in vertebrate biology that hasn’t been amenable 
for functional proteomics is the African clawed frog Xenopus laevis. Research carried out 
on Xenopus oocytes and egg extracts has produced insights into the cell cycle[97], 
microtubule cytoskeleton regulation by associated proteins[98], and spindle formation[99, 
100]. Despite the importance of Xenopus laevis, its large 3070-megabase pseudotetraploid 
genome[101] remains unsequenced, and the genome of Xenopus tropicalis is planned to be 
sequenced by the DOE Joint Genome Institute by 2005, which significantly limits the rate at 
which isolated proteins can be identified. Currently, sequences of less than 7000 Xenopus 
proteins are present in a publically available DB despite a public initiative in EST 
sequencing (less than 221,000 largely unannotated ESTs are available, August 16, 2002, 
both figures from http://www.ncbi.nlm.nih.gov/). Taken together current DB resources 
don’t provide an adequate coverage of Xenopus’ large 3070-megabase pseudotetraploid 
genome[101]. 
Below, alternative MS data interpretation approaches (see 2.5.1) and specialized DB 
searching softwares were applied to characterize the Xenopus microtubule-associated 
proteome. 
  
2.2.2 Mass Spectrometry Analysis of Microtubule-Associated Proteins 
Microtubule-associated proteins (MAPs) from Xenopus laevis egg extracts were isolated 
through binding and subsequent elution from microtubules using ATP or salt. The eluted 
proteins were resolved by one-dimensional gel electrophoresis and identified by MS. A first 
screen was conducted for proteins with a high degree of sequence similarity compared to 
available DB sequences using PMF, and proteins not identified by PMF were subjected to 
MS/MS analysis. The conventional MS/MS spectra analysis and DB searching software 
compares lists of observed fragment masses with predicted fragment ion masses to identify 
peptides that are highly similar to DB entries[102,103]. If a close homologue of the 
analyzed protein is not in a DB, conventional protein identification methods fail. In these 
cases, sequence-similarity approaches were used to identify homologous proteins beyond 
the limits of the conventional software. 
  
                                                                                                                                         49
From three gel lanes, 55 protein bands were analyzed and 61 proteins were 
identified by MS (Figures 8 & 11). The conventional software identified 20 proteins by 
PMF and 19 proteins from MS/MS spectra.  From the same set of MS/MS spectra, 
sequence-similarity DB searching by MS BLAST identified 24 proteins and MT identified 
41 proteins (this included all of the proteins identified by the conventional software and MS 
BLAST but one, plus 17 more) (Table 6). The presence of three known microtubule 
associated proteins was confirmed by Western blot (Figure 9). 
In this screen, unknown Xenopus proteins were analyzed by NanoESI-MS/MS (Figure 
10) and the resulting tandem mass spectra were used to generate peptide sequences for DB 
searching. In one example, upon DB searching a protein was simultaneously aligned to Bos 
taurus, Mus musculus, Rattus norvegicus, Homo sapiens, Saccharomyces cerevisiae, and 
Arabidopsis thaliana DB entries, demonstrating that some proteins are widely 
phylogenetically conserved and that DB entries from many distantly-related species can be 
used for protein identification (Table 4).  To identify all of the proteins in the screen above, 
proteins were identified using Xenopus DB entries, making 29 determinations, and 32 
proteins were identified by cross-species reference to homologous sequences from Homo 
sapiens, Mus musculus, Rattus norvegicus, Cricetulus griseus, Sus scrofa, Gallus gallus, 
Gillichthys mirabilis, Paralichthys olivaceus, Salmo salar, Danio rerio, Paracentrotus 
lividus, Caenorhabditis elegans, Drosophila auraria, and Thermosynechococcus elongatus.  
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4. Glutamyl-prolyl-tRNA synthetase, XP_001958
5.   Glutamyl-prolyl-tRNA synthetase, XP_001958
6.   Xklp1, I51617
7.   Isoleucyl-tRNA synthetase, P41251
8. Hyaluronan mediated motility receptor, BG363849
9. Leucyl-tRNA synthetase, BAA95667
Kinesin-related motor protein Eg5, Q91783
Imitation switch ISWI, AAG01537
10. DNA polymerase delta, S35455
11. Kinesin 5B, NP_032474
12. Kinesin 5C, NP_004513
13. Poly [ADP-ribose] polymerase, P31669, Echinoderm microtubule-associated protein
(EMAP-4), NP_061936
14. Heat shock protein 90, NP_571385, Glutaminyl-tRNA synthetase, NM_005051
15. XNF7, AAB35876
16. XNF7, AAB35876
17. XNF7, AAB35876
18. Xklp3A, CAC33801
19. Heat shock protein 70.II, AAB41583
20. Lysyl-tRNA synthetase, BAA06688
21. Alpha tubulin, P08537, Formiminotransferase-cyclodeaminase
(FTCD), P53603
22. Alpha tubulin, CAA30093, Beta tubulin, B27554
23. Beta tubulin, S05968 
24. Elongation factor gamma, I51237
25. Elongation factor 1-beta, P30151 
Crude 
Extract
ATP
Elution
NaCl 
Elution
A.
26. Pancreatic trypsin inhibitor, 1FAN
Conventional Methods                               Sequence-Similarity Methods
 
Figure 8A   Identification of Xenopus MAPs.  
The analysis of protein bands by in-gel digestion and mass spectrometry identified proteins eluted from 
microtubules by NaCl (A) and ATP (B). Conventional protein identification methods include: peptide mass 
fingerprinting, and conventional MS/MS spectra interpretation software. Sequence-similarity identification 
methods include: MS BLAST and MT. All proteins in the first column that were identified by MS/MS were 
identified by conventional and sequence-similarity methods. However only sequence-similarity methods 
identified proteins in the second column. Components: ARS complex (red), EF-1 complex (Green). Molecular 
mass markers are in kilo Daltons. (in collaboration with Dr. Andrei Popov). 
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16. 60S Ribosomal protein L5B, P15126
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Figure 8B   Identification of Xenopus MAPs. 
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Figure 9  Immunoblot of Xenopus NaCl elution fractions. 
NaCl-eluted proteins were resolved on a 6% polyacrylamide gel and blotted onto a nitrocellulose membrane. 
Blot was probed with antibodies for XMAP215 (lane 1), XMAP230 and XMAP310 (lane2). Positions of the 
molecular weight markers are on the left hand side, in kilo Daltons. (in collaboration with Dr. Andrei Popov) 
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Figure 10  Time-of-Flight mass spectrum of an in-gel tryptic digest of a 120 kDa Xenopus protein.  
Tandem mass spectra were acquired from peaks designated with m/z. Peaks originating from trypsin autolysis 
products are designated with T. Peaks of the peptides, which matched the sequence of bovine DNA polymerase 
delta are labeled with asterisks. 
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Table 4  Identification of a Xenopus Protein by MS BLAST Sequence-Similarity Searching. 
M/z z 
Precursor  
Mass Manual Interpretation  AUTO BOVINE MOUSE RAT HUMAN YEAST ARABIDOPSIS Score 
407.77 2 813.52 BVVSZLLR / + + + +   47 
414.75 2 827.49 BLLEZGLR / + + + +   46 
435.91 3 1304.70 BXXXTAVLZD YES   +     
440.76 2 879.50 BLAVYD YES       - 
444.27 3 1329.79 BXXAHFNTAVLK, BXXXAHFNTAVLK YES       - 
449.25 3 1344.73 BXXXXADLL, BXXXXXADLL NONE       - 
467.25 2 932.49 BTPTPT NONE       - 
487.74 2 973.46 BYTLDDGYK YES + + + +   42 
512.29 2 1022.57 BVSTFPG YES       - 
519.76 2 1037.52 BTPTGDZV YES + + + +   41 
536.79 2 1071.56 BLALZDPFLR YES       - 
546.77 2 1091.52 BLQDLSDFZK YES       - 
566.82 2 1131.62 BLFEPLL YES + + + +   51 
588.31 2 1174.60 BVLSFDLE NONE + +  +  + 53 
598.31 2 1194.62 BYGLNPEDFLK YES  + +     
623.84 2 1245.66 BXXSZLSALEEK YES + + + +   54 
640.82 2 1279.65 BVLSFDLEE / + +  +   54 
709.33 2 1416.65 BXXEVPDZ NONE       - 
745.41 2 1488.80 BXXXTVAEA, BXXXXTVAEA YES       - 
792.95 2 1583.89 BXADSVYGFT, BXXADSVYGFT YES + + + + + + 58 
883.44 2 1764.86 BXXXEDYTZTVLE, BXXXEDYTGATVLE YES + + + + +  72 
 
Fragmentation of peptide ions in Figure 10 enabled the production of the query above. Bovine DNA 
Polymerase delta was the top hit, scores of individual HSPs are presented. Sequence stretches in bold and 
underlined matched the bovine sequences exactly. Spectra that the software was unable to automatically predict 
sequences for are labeled “NONE.”  Spectra with automatically predicted sequences are labeled “YES”.  In 
spectra labeled “/,” no automatically predicted sequences were included because high quality sequences were 
retrieved directly from y-ion series in the spectrum. 
 
 
2.2.3 Proteins Identified in Xenopus MAP Screen 
The identified proteins can be grouped in three classes: 1) previously described MAPs and 
motors, 2) proteins reported to be associated with the microtubule cytoskeleton, but without 
a known cytoskeletal function (Heat shock proteins), and 3) proteins not previously 
described as having microtubule localization (Table 5). In the first and second groups, 
several known kinesins as well as dynein heavy and intermediate chains were identified, 
and four previously characterized MAPs. Among the proteins of the third group 
components of two multiprotein complexes were detected. These are: four subunits of the 
750-kD guanine nucleotide exchange EF-1βγδ complex[104], and seven aminoacyl-tRNA 
synthetases known to form a multicomponent complex thought to exist in all higher 
eukaryotes[67].  The aminoacyl-tRNA synthetase (ARS) complex has been shown to 
consist of eight to nine aminoacyl-tRNA synthetases and three non-synthetase components. 
The ARS complex is essential for aminoacylation of tRNAs prior to polypeptide synthesis 
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(rev. in [67]) and the EF-1 complex exchanges GTP/GDP in the binding and transportation 
of aminoacyl-tRNAs to the ribosome[104]. 
 
Table 5  Proteins Identified in the Microtubule-Bound Fractions 
(1) MAPs and Motor Proteins    
  Protein Localization/function ID type 
1 Dynein heavy chain ATPase domain-containing chain of the dynein complex[105] Cr 
2 XMAP310 Figure 9[106]  AB 
3 XMAP230 Figure 9[107]  AB 
4 XMAP215 Microtubule-associated protein, regulation of microtubule dynamics[84] X.l.,AB 
5 Xklp1 Chromokinesin[108] X.l. 
6 Eg5 Plus-end-directed microtubule motor[109],[110] X.l. 
7 Kinesin 5B Kinesin heavy chain member 5B[111] Cr 
8 Kinesin 5C Neuron-specific kinesin heavy chain member 5C[112] Cr 
9 EMAP4 a WD repeat protein, localizes to microtubules and 
promotes microtubule dynamics[113] 
Cr 
10 Xklp3 Kinesin II motor protein, Figure 12 X.l. 
11 Xklp3A Kinesin II motor protein[114] X.l. 
12 Dynein intermediate chain Part of the dynein minus-end motor complex[115] X.l. 
13 Alfa tubulin Part of the alpha-beta tubulin dimer[116] Cr, X.l. 
14 Beta tubulin Part of the alpha-beta tubulin dimer[117] Cr, X.l. 
(2) Proteins with previously described microtubule cytoskeleton localization 
1 RHAMM, (Hyaluronan 
mediated motility receptor) 
RHAMM was reported to be associated with microtubuless in interphase and mitotic cells as well as with 
microtubules in vitro[118] 
X.l. 
2 ISWI (imitation switch protein) ATP-dependent chromatin-remodeling factor[119, 120] X.l. 
3 Poly (ADP-ribose) polymerase 
(PARP) 
Telomeres, mitotic centrosomes[121] X.l. 
4 Heat shock protein 90 Microtubules, centrosome[122, 123] Cr 
5 Heat shock protein 70.II Microtubules[122] X.l. 
6 XNF7  Xenopus nuclear factor 7, protein with function in dorsal/ventral patterning of the embryo. In mitosis 
localizes to mitotic spindle[124] 
X.l. 
7 FTCD Formininotransferase cyclodeaminase, microtubule-binding Golgi protein[125] Cr 
 (3) Proteins not previously described as having microtubule localization   
1 Ataxia telangiectasia  protein Chromatin-binding protein[126] X.l. 
2 Ataxia telangiectasia protein  Chromatin-binding protein[127] X.l. 
3 Glutamyl-prolyl-bifunctional 
aminoacyl tRNA synthetase 
Part of a multicomponent aminoacyl-tRNA synthetase complex[67] Cr 
4 Isoleucyl-tRNA synthetase Part of a multicomponent aminoacyl-tRNA synthetase complex[67] Cr 
5 Leucyl-tRNA synthetase Part of a multicomponent aminoacyl-tRNA synthetase complex[67] Cr 
6 DNA-polymerase delta, 
catalytic subunit 
Part of the three-subunit DNA polymerase delta[128] Cr 
7 eEF-2 Translation Elongation factor[129] Cr 
8 Glutaminyl-tRNA synthetase Part of a multicomponent aminoacyl-tRNA synthetase complex[67]  Cr 
9 Arginyl-tRNA synthetase Part of a multicomponent aminoacyl-tRNA synthetase complex[67] Cr 
10 Lysyl-tRNA synthetase Part of a multicomponent aminoacyl-tRNA synthetase complex[67] Cr 
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Table 5  continued
SP70/HSP90 organizing 
otein 
Stress-response protein[130] X.l. 
spartyl-tRNA synthetase Part of a multicomponent aminoacyl-tRNA synthetase complex[67] Cr 
 1-gamma Beta, delta and gamma subunits of EF1 form a guanine nucleotide exchange complex (co-localize with the 
endoplasmic reticulum)[104] 
X.l. 
 1-alpha Substrate of the guanine-nucleotide exchange complex[104]  X.l. 
 1-delta-2 Homologous to the EF-delta-1, part of the guanine-nucleotide exchange complex of elongation factor-1 (EF-
1)[104] 
X.l. 
S Ribosomal protein L5B  60S subunit ribosome-binding protein. Was previously described in association with the ARS complex[131] X.l. 
S Ribosomal protein S3A 40S ribosomal subunit[132] X.l. 
ctivated protein kinase C 
ceptor (RACK1) 
RACK1 is a highly conserved WD protein expressed during embryogenesis[133] X.l. 
 1-beta Part of the guanine nucleotide exchange complex of EF-1[104] X.l. 
ified proteins are grouped into three categories (see text). Proteins were identified (ID Type) by mass 
rometry and reference to Xenopus laevis database sequences (X.l.) or cross-species referenced to 
nces other than Xenopus (Cr). Tubulin monomers were identified with Xenopus and other species entries, 
we detected both Xenopus and pig tubulins. Additional identifications were made by immunoblot analysis 
 specific antibodies (AB). (in collaboration with Dr. Andrei Popov) 
 
 Association of the ARS Complex with Microtubules 
hysical interaction of the ARS complex with meiotic microtubules has not been 
rved previously. The ARS was examined to determine if it could be a cargo complex, 
ciated via a motor protein to microtubules. ATP eluted proteins were fractionated on a 
ose density gradient and resolved by SDS-PAGE. A fraction was identified that 
ded seven aminoacyl-tRNA synthetases and dynein heavy chain (Figure 11). Whereas 
lanes contained this pattern, one lane contained only the ARS complex but no dynein 
y chain (data not shown).  
As p50 (dynamitin) disrupts the dynein/dynactin interaction in vivo and in 
[134], we examined whether p50 would dissociate the ARS complex from 
otubules in the presence of dynein. After p50 addition, some proteins like XNF7 
opus Nuclear Factor 7) disappeared from the microtubule pellet, but we still detected 
S/MS the ARSs in the bound fraction (Figure 12). The ARS complex was eluted from 
otubules with excess ATP, along with other kinesin proteins whose association is 
n to be ATP-dependent. Furthermore, ATP added to the egg extract also prevented the 
 complex from binding to microtubules. We therefore concluded that the binding of the 
 complex to microtubules is specific and ATP-sensitive. These experiments suggest 
the ARS complex is not a “classical” dynein/dynactin cargo. Since MS analysis of 
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other, minor protein bands present in the ARS-containing fraction did not detect any other 
motor proteins, we concluded that the ARS complex binds to microtubules directly.  
 
1. Dynein heavy chain, BAA02996
4. Glutamyl-prolyl-tRNA synthetase, XP_001958
5. Isoleucyl-tRNA synthetase, P41252
6. Leucyl-tRNA synthetase, BAA95667 
7. Glutaminyl-tRNA synthetase, NP_005042
2. Ataxia telangiectasia mutated, AAF20175
8. Arginyl-tRNA synthetase, P54136
10. Aspartyl-tRNA synthetase, P14868
9. Lysyl-tRNA synthetase, Q15046
3. Ataxia telangiectasia, AAG40002 250-
50-
75-
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150-
 
Figure 11  Xenopus ARS complex purification. 
Microtubule-bound proteins were eluted by ATP and further fractionated on a density gradient, with one 
unique fraction corresponding to ca. 15S shown above. Seven aminoacyl-tRNA synthetases co-migrated on a 
sucrose density gradient with dynein heavy chain. Components of the ARS complex (Red). (in collaboration 
with Dr. Andrei Popov) 
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Figure 12  Isolation of the motor faction in the presence of p50. 
Coomassie-Blue-stained gradient (6-20%) polyacrylamide SDS-gel showing the proteins bound to 
microtubules under different conditions and eluted from them with 20mM ATP. The lanes show from left to 
the right: 1. Molecular weight markers, in kiloDaltons; 2. Proteins bound to microtubules from native extract 
(control); 3. Proteins bound in the presence of AMP-PNP; 4. Proteins bound in the presence of AMP-PNP and 
p50; and 5. Proteins isolated from native extracts supplemented with 10 mM ATP. The major band above the 
50 kD marker corresponds to alpha and beta tubulin (data not shown). (in collaboration with Dr. Andrei Popov) 
 
 
2.2.5 In vitro Spindle Reconstitution and Electron Microscopy 
We have demonstrated that two essential components of the protein translation machinery, 
EF-1 complex and the ARS complex are bound to microtubules in meiotic egg extracts. 
These findings suggested that protein translation may be spatially connected with the 
spindle. To verify this hypothesis, we assembled spindles in Xenopus egg extracts and 
analyzed their structure by electron microscopy. Remarkably, we detected ribosomes, that 
appeared in clusters located peripheral to the centrosomes (Figure 13a) and were distributed 
along the length of the spindle microtubules (Figure 13b), further suggesting that the protein 
translation machinery is localized on the spindle in vivo.    
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Figure 13  Electron micrographs of the Xenopus In vitro-reconstituted spindle.  
A) Initial low magnification images show ribosomes in clusters located peripheral to the centrosomes. B) Upon 
higher magnification, ribosomes were found to be distributed along the length of the spindle microtubules. (in 
collaboration with Dr. Peg Coughlin) 
 
2.2.6 Biological Implications of Xenopus Experiments 
(in collaboration with Dr. Andrei Popov and Professor Eric Karsenti) 
Due to the large size of Xenopus oocytes and the fact that they contain an abundance of 
cytoplasmic proteins for early development, these cells or extracts prepared from them have 
been the preferred model system for the study of the mitotic spindle and spindle-associated 
proteins[100]. For example, MAPs have been analyzed by purification and MS from other 
organisms, such as human, Drosophila, and yeast. However, from the sixteen microtubule-
bound proteins purified by Mack and Compton in 2001 from mitotic HeLa cells, only two 
are on the list of proteins identified above (Eg5 and HSP70)[135]. In a systematic analysis 
of centrosome-associated proteins (and many MAPs are also centrosomal components, 
see[136]) from Drosophila, only one identified protein was also found in our preparation 
(HSP90)[123]. Of the eight proteins identified by Adams and Kilmartin from 
Saccharomyces cerevisiae spindle pole bodies, none matches those found in our 
preparation[137]. Comparing these studies with our results demonstrates the utility of the 
Xenopus oocyte as a model system. 
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The finding that the ARS complex and the EF-1 complex of the protein translation 
machinery are bound to microtubules in egg extracts, and electron micrographs showing 
ribosomes on the reconstituted spindle, prompts speculations about the potential existence 
of such interactions in vivo. The ARS and EF-1 complexes were identified primarily in the 
ATP-elution samples and, interestingly, there is evidence that they may interact with each 
other in vitro[138]. From our results, it could be suggested that protein translation during 
meiosis occurs on spindle microtubules. Indeed, ribosomes have also previously been found 
on microtubules isolated from sea urchin unfertilized eggs, and their attachments were 
mediated through another protein found in our screen (EMAP)[139]. Spatial regulation of 
translation could be especially important for large cells like the Xenopus oocyte. Although 
transcription of cyclin B1[140] does occur during mitosis, protein synthesis has not been 
directly detected in mitotic cells.  On the contrary, de novo synthesis of several cell cycle 
components, including c-mos, cyclin B1, and XKID is essential during meiosis[141,142]. 
Furthermore, cyclin B1 mRNA was found associated with meiotic spindles and it was 
suggested that translation of cyclin B1 occurs locally, “on or near spindles and 
centrosomes”[143]. These findings lend support to this interpretation. 
These findings demonstrate the power of sequence-similarity protein-identification 
methods combined with cell biological approaches for the functional proteomics of 
organisms outside the boundaries of sequenced genomes.  
  
Table 6 Xenopus Protein Identifications and Statistics 
 
No. 
Peptide Mass Mapping 
-Mascot 
MS/MS 
-Mascot 
MS/MS 
-MSBLAST  
MS/MS 
-MultiTag BLS BLH MS MT TH C H XE EM S MA E -value PredCount
1. NaCl elution lane (Figure 8A)                            
1 
Dynein heavy chain 
R. norvegicus, AAA41103           / / / / / / / / / / / 
2 
XMAP 215kD 
Xenopus, CAB61894     / / / / / / / / / / / 
3 
XMAP 215kD,  
Xenopus, CAB61894     / / / / / / / / / / / 
4    
Glutamyl-prolyl-tRNA synthetase 
H. sapiens, XP_001958 16 11 3 2 4 41 1 1 0.1 1.08E-05 2.84E-14 
5  
Bifunctional aminoacyl-tRNA  
Synthetase H. sapiens, P07814 
Glutamyl-prolyl-tRNA synthetase 
H. sapiens, XP_001958 12 9 5 3 5 12 3 2 0.1 5.30E-08 3.09E-24 
6 Xklp1, Xenopus, I51617      / / / / / / / / / / / 
7 
Isoleucyl-tRNA synthetase       
PMF match to ATP 4     / / / / / / / / / / / 
8    
Hyaluronan mediated motility  
Receptor, Xenopus(EST)BG363849 12 9 0 0 0 35 0 3 0.1 / / 
9    ISWI, Xenopus, AAG01537   14 12 2 2 7 29 5 2 0.1 1.72E-03 2.83E-08 
9    Eg5 , Xenopus, Q91783   14 12 2 1 1 29 13 2 0.1 1.26E-02 1.94E-05 
9    Leucyl-tRNA synthetase*   14 12 4* 0 4 29 0 0 / / / 
10   
DNA polymerase delta 
H. sapiens, P28340  
DNA polymerase delta  
H. sapiens, S35455 145 3 12 12 5 2 13 31 1 1 0.1 8.14E-07 1.26E-16 
11   
Kinesin heavy chain 
Xenopus, AJ249840 
Kinesin 5B 
M. musculus, NP_032474 139 3 12 9 4 3 33 11 5 5 0.1 5.05E-08 6.94E-18 
12  
Kinesin 5C  
M. musculus, AAC79804  
Kinesin heavy chain 
  M. musculus, L27153 
Kinesin 5C 
H. sapiens, NP_004513 387 9 15 10 5 1 19 5 3 4 0.1 3.40E-08 3.54E-17 
13  
Poly [ADP-ribose] polymerase  
Xenopus, P31735 
Poly [ADP-ribose] polymerase 
Xenopus, P31669   14 11 4 4 2 88 5 2 0.1 1.00E-04 9.95E-17 
13   
EMAP 
H. sapiens, Q9HC35 EMAP, H. sapiens, NP_061936 134 2 14 12 2 1 0 88 1 1 0.1 4.57 8.56E-03 
14  
Heat shock-like protein 
M. musculus. CAA34748 
Heat shock protein 90-beta  
S. salar, AF135117 
Heat shock protein 90-beta 
D. rerio, NP_571385 184 4 14 5 5 3 38 190 35 3 0.1 4.35E-09 3.87E-19 
14   
Glutaminyl-tRNA synthetase 
M. musculus, AK003794 
Glutaminyl-tRNA synthetase 
H. sapiens, NM_005051 104 2 14 8 5 2 7 190 14 8 0.1 6.26E-08 7.95E-16 
15 
XNF7 
 Xenopus, AAB35876     / / / / / / / / / / / 
16 
XNF7  
Xenopus, AAB35876     / / / / / / / / / / / 
17 
XNF7 
Xenopus, AAB35877     / / / / / / / / / / / 
18 
Xklp3A 
Xenopus, CAC33801     / / / / / / / / / / / 
19 
Heat shock protein 70  
Xenopus, AAB41583     / / / / / / / / / / / 
20    
Lysyl-tRNA synthetase 
H. sapiens, BAA06688  15 9 5 4 10 71 21 4 0.1 1.07E-07 3.80E-24 
21   
Formiminotransferase  
cyclodeaminase 
 H. sapiens, AF289023 
Formiminotransferase  
Cyclodeaminase 
S. scrofa, P53603 169 3 16 12 2 0 7 172 8 4 0.1 2.18E-01 3.49E-04 
21  
Tubulin alpha 
G. mirabilis. AAL24509 
Tubulin alpha 
Xenopus, P08537   16 4 3 3 179 172 118 3 0.1 7.11E-10 1.02E-14 
22   
Tubulin beta 
H. sapiens, BC020171 
Tubulin beta-5 
G. gallus, B27554 350 8 18 10 4 3 289 251 25 2 0.1 2.19E-07 3.19E-17 
22  
Tubulin alpha 1 
H. sapiens, AAH06468  
Tubulin alpha 
P. lividus, A60671 
Tubulin alpha 
Xenopus, CAA30093 267 5 18 7 6 6 268 251 137 7 0.1 2.72E-08 3.39E-33 
23 
Tubulin beta-2 
Xenopus, S05968      / / / / / / / / / / / 
24 
Elongation factor gamma 
Xenopus, I51237     / / / / / / / / / / / 
25  
Elongation factor 1-beta 
 Xenopus, CAA49418  
Elongation factor 1-beta 
Xenopus, P30151 
Elongation factor 1-beta 
Xenopus, P30151 250 5 13 7 7 4 3 26 26 1 0.1 2.12E-08 1.06E-32 
26   
Pancreatic trypsin inhibitor 
B. taurus, P00974 
Pancreatic trypsin inhibitor 
 B. taurus, X04666 
Pancreatic trypsin inhibitor 
B. taurus, 1FAN 160 3 10 6 3 3 43 36 0 0 0.1 1.07E-08 2.00E-16 
2. ATP elution lane (Figure 8B)                   
1 
Dynein heavy chain 
R. norvegicus, A38905         / / / / / / / / / / / 
2    
Glutamyl-prolyl-tRNA synthetase 
H. sapiens, XP_001958 10 9 3 1 7 21 15 4 0.1 7.14E-07 1.09E-09 
3    
Glutamyl-prolyl-tRNA synthetase 
H. sapiens, XP_001958 8 4 1 1 0 4 1 1 0.1 15.35 4.45 
4    
Isoleucyl-tRNA synthetase 
H. sapiens, P41252  10 9 3 1 4 22 0 0 0.1 2.73E-05 2.89E-08 
5    Eg5, Xenopus, Q91783   10 7 1 1 0 6 1 1 1 19.79 0.75 
6  
Kinesin heavy chain, 
M. musculus, AAC06326 
Kinesin heavy chain  
M. musculus, X61435 
Kinesin 5B 
M. musculus, NP_032474 109 2 15 8 3 3 15 3 1 3 1.5 1.37E-05 1.01E-10 
7 
Kinesin heavy chain 
H. sapiens, A41919     / / / / / / / / / / / 
8  
Elongation factor eEF-2  
R. norvegicus, CAA68805 
Elongation factor eEF-2 
C. elegans, A40411  10 6 4 3 65 50 50 2 0.1 7.99E-07 1.02E-13 
9 
Heat shock protein 90 
H. sapiens, P07900      / / / / / / / / / / / 
10   
Cytoplasmic dynein  
intermediate chain 
 Xenopus, AF319781 
Cytoplasmic dynein  
intermediate chain 
Xenopus, AF319781 179 3 18 9 5 5 7 63 17 5 0.1 6.25E-28 1.80E-07 
11  
Heat shock protein 70.II  
Xenopus, AAB00199 
Heat shock protein 68 
D. auraria, AF247553 
Heat shock protein 70 
P. olivaceus,  AAC33859 106 2 20 4 3 2 31 167 167 2 0.1 4.09E-09 5.78E-10 
12    
Lysyl-tRNA synthetase 
H. sapiens, Q15046  15 4 1 1 6 81 25 2 0.1 1.56 6.58E-02 
13   
HSP70/HSP90  
organizing protein 
C. griseus, AAB94760 
HSP70/HSP90 
organizing protein 
C. griseus, AAB94760 168 3 16 7 4 0 6 25 13 2 0.1 7.82E-09 6.43E-14 
14  
Elongation factor 1-gamma  
Xenopus, AAB29957 
Elongation factor 1-gamma 
Xenopus, AAB29958 
Elongation factor 1-gamma 
Xenopus, I51237 168 7 22 8 8 6 3 100 100 6 0.1 4.12E-08 5.38E-41 
14  
Elongation factor 1-alpha 
Xenopus, CAA37169 
Elongation factor 1-alpha 
Xenopus, P17507 
Elongation factor 1-alpha 
Xenopus, P17508 379 8 22 11 5 5 4 95 95 5 0.2 8.35E-07 3.03E-22 
15  
Elongation factor delta-2  
Xenopus, S57631 
Elongation factor  
1-beta/delta 
C. elegans, P34460 
Elongation factor delta-2 
Xenopus, S57631 106 2 9 5 4 3 2 46 46 3 0.1 2.49E-09 3.53E-18 
16    60S Ribosomal protein L5B   6 5 2 1 17 66 39 2 0.1 2.21E-07 5.36E-09 
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Table 6  continued
Xenopus, P15126 
 
Ribosomal protein S3 
M. musculus, AAH10721 
40S ribosomal protein S3B 
Xenopus, P47835 
40S Ribosomal protein S3A 
Xenopus, P02350 98 1 18 7 2 2 21 120 20 2 0.1 9.86E-05 1.24E-07 
 
Activated protein kinase C receptor 
Xenopus, AAD42045 
Activated protein kinase  
C receptor 
Xenopus, AAD42045 18 7 2 1 1 120 100 2 0.1 4.98E-03 5.60E-05 
  
Elongation factor 1-beta 
Xenopus, P30151 
Elongation factor 1-beta 
Xenopus, P30151 266 5 7 5 5 4 18 70 70 5 0.3 2.75E-09 1.16E-20 
  
Pancreatic trypsin inhibitor 
B. taurus, P00974 
Pancreatic trypsin inhibitor 
B. taurus, 1FAN   10 4 2 2 40 1 0 0 0.1 3.82E-07 3.64E-08 
actionation lane (Figure 11)                           
Dynein heavy chain  
R. norvegicus, BAA02996         / / / / / / / / / / / 
   
Ataxia telangiectasia  
Xenopus, AAF20175  5 5 2 2 0 0 0 0 0.1 8.88E-11 4.07E-07 
  
Ataxia telangiectasia 
Xenopus, AAG40002  150 3 / / / / / / / / / / / 
Glutamyl-prolyl-tRNA  
Synthetase  
PMF match to ATP 2    
Glutamyl-prolyl-tRNA synthetase 
Xenopus, EST, BI443016 / / / / / 40 14 3 / / / 
Isoleucyl-tRNA 
synthetase  
PMF match to ATP 4       / / / / / / / / / / / 
 
Leucyl-tRNA synthetase 
H. sapiens, BAA95667          
Leucyl-tRNA synthetase 
H. sapiens, BAA95667 
Leucyl-tRNA synthetase 
H. sapiens, BAA92590 416 8 14 7 3 1 2 / / / / 7.73E-05 1.50E-07 
Glutaminyl-tRNA 
synthetase  
PMF match to NaCl 14       / / / / / / / / / / / 
  
Arginyl-tRNA synthetase 
H. sapiens, P54136 
Arginyl-tRNA synthetase 
T. elongatus,  NP_681615   439 9 12 7 2 1 17 / / / / 3.42E-05 4.95E-03 
Lysyl-tRNA synthetase 
 PMF match to NaCl 20      / / / / / / / / / / / 
  
Aspartyl-tRNA synthetase 
H. sapiens, AAH00629 
Aspartyl-tRNA synthetase 
H. sapiens, P14868 
Aspartyl-tRNA synthetase 
H. sapiens,  P14868 361 6 10 5 5 4 2 / / / / 2.98E-21 3.55E-09 
tein bands were analyzed by peptide mass fingerprinting and Mascot database searching (Blue) from the 
Cl elution lane (section 1), ATP elution lane (section 2), and Density Gradient fractionation lane (section 3). 
e set of tandem mass spectra was analyzed by Mascot (Orange), MS BLAST (Red), and MultiTag (Green). 
S: MS BLAST score, BLH: no. of high scoring pairs in MS BLAST identification, MS: no. of MS/MS 
uired where sequence tag interpretation was attempted, MT: no. of complete tags submitted to MT, TH: no. 
tags in top MT hit, C: no. of complete tags in top hit, H: hits that are homologues to the top MT hit with E-
lues <0.1, including the top hit, XE: no. of Xenopus ESTs retrieved from non-error-tolerant searches with all 
uence tags from the analysis of the digest, EM: no. of Xenopus ESTs matching the top MT hit, S: no. of 
uence tags matching Xenopus ESTs matching the top MT hit, MA: mass accuracy in Daltons used in MT 
aluation, E: E-values calculated by MT. PredCount: Predicted Count calculated by MT. *Each individual 
uence tag matched to a different database entry from four different species. Identifications in Black were 
ntified by EST DB searching. 
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2.3 Dunaliella salina Functional Proteomics 
2.3.1 Plant Proteomics 
The characterization of proteomes is a precise method to identify the proteins, and their 
corresponding genes, which act together to produce the unique biochemistry and physiology 
of cells. The proteomes of plants have been characterized in multiple species, such as 
Arabidopsis[144], rice[145], maize[77], pea[79], wheat[146], and poppy[81], among others. 
The sequencing of the Arabidopsis[11] and rice genomes[9,10] has facilitated proteomic 
research into these organisms. Genome sequences and corresponding protein sequence 
databases provide a reference for the identification of proteins by the correlation of 
analyzed peptide fragments with in silico sequences by MS and DB searching. 
Conventional protein-identification algorithms, such as Mascot[102] and SEQUEST[147], 
correlate mass data from the mass spectra of protein digests (PMF) or fragment ion tandem 
mass spectra of peptides (produced by the proteolytic digestion of whole proteins), and are 
primarily capable of exact matching (reviewed in[16]), subsequently restricting proteome 
characterization in many plant species with unsequenced genomes (reviewed in[148]).  
Despite this limitation, homologous proteins in different species often have conserved 
amino acid sequences, enabling existing DB entries to serve as a reference for the 
identification of homologous proteins in other phylogenetically related species.  
Here MS and multiple DB searching strategies were applied simultaneously 
(reviewed in section 2.5.3) to characterize the proteome of the green alga Dunaliella salina. 
Dunaliella can adapt to the most hypersaline conditions on earth. As such it is recognized as 
a model photosynthetic organism for analyzing salinity tolerance. In contrast, most plants 
can adapt to low or moderate salinities and their growth is severely limited at salinities 
exceeding 200 mM NaCl[149].  
Differential mRNA screens carried out in Arabidopsis thaliana and rice have shown 
that plants respond to salt stress by up-regulation of expression of a large number of genes 
involved in diverse physiological functions[150-153]. Dunaliella responds to salt stress by 
massive accumulation of glycerol, the internal osmotic element in Dunaliella, by enhanced 
elimination of Na+ ions and by accumulation of distinct proteins[154]. However, no 
comprehensive analysis of salt up-regulated genes/proteins has been carried out in 
Dunaliella, mainly due to absence of sufficient genomic information. Sequence information 
for D. salina is limited to approximately 50 protein entries and 3000 nucleotide entries in 
NCBI (August, 2003), thus restricting the ability to identify proteins by MS using 
conventional methods. 
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The conventional DB-searching algorithm, Mascot, and two sequence-similarity 
DB-searching algorithms, MS BLAST and MultiTag, and protein and EST DB searching, 
were applied for the identification of proteins from 2D gels. In an attempt to characterize 
Dunalella’s unique physiology resulting in resistance to high saline conditions, we 
identified 61 proteins that are up-regulated in 3M salt, from three sub-cellular fractions: 
crude plasma membrane, chloroplast soluble proteins, and cytosol. The induced proteins 
included many members of the Calvin cycle, starch biosynthesis and degradation, amino 
acid biosynthesis, energy production, chaperones, and protein synthesis and degradation. 
Sequence-similarity protein identification techniques were essential for effective 
identification of more than half of the proteins analyzed. From these results, we expect the 
proteomics of many plants with unsequenced genomes to be more amenable to 
characterization than previously facilitated by conventional methods.  
 
2.3.2 Analysis of Dunaliella Proteins by Mass Spectrometry 
D. salina cells were cultured in 0.5M or in 3M NaCl, and  fractionated into crude plasma 
membrane, cytoplasmic soluble, and chloroplast soluble fractions. After separation of each 
fraction on 2-D gel electrophoresis the spots were differentially analyzed to identify 
components up-regulated by high salt (Figure 14A, B, C). In general, the fractionation 
elevated the overall number of salt up-regulated spots (>2-fold induction) from 30 in a total 
cell protein extract to 75 (+ 3 references) in the combined 3 fractions after exclusion of 
cross-contaminations between fractions (data not shown).  
Initial peptide mass fingerprinting analysis of spots up regulated in the total cell 
extract failed to identify any protein (data not shown). From the three cellular fractions, 
PMF was able to identify 9 of 78 spots using reference protein DB sequences from 
Dunaliella sp. and Chlamydomonas sp., among others (Table 7). The remaining 69 proteins 
from the three 2-D gels were analyzed by nanoelectrospray MS/MS and Mascot protein DB 
searching, which identified 23 additional proteins (in one case two proteins were identified 
in one spot).  
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A. Crude plasma membrane (3M NaCl) 
 
B. Cytoplasmic soluble (3M NaCl)  
 
C. Chloroplast soluble (3M NaCl)  
    
 
Figure 14 Dunaliella 2-D gel protein separation 
 
Proteins were first resolved by isoelectric point from pH of 3-10 or 4-7, then according to 
mass, ~21-200kiloDaltons. Gels were stained with Coomassie. (in collaboration with Dr. 
Adriana Katz) 
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Table 7  Dunaliella Protein Identification  
Spot Protein Identifications F.I. OMW TMW Species  Accession  PF Ma-EST/Ac Ma MB MT 
  Antioxidation                     
B30 Iron-superoxide dismutase pre. 3 27 27 V. unguiculata AAF28773   1   
B31 Thioredoxin peroxidase 2 26 22 T. elongatus BAC09006  2 3   
C21 Thioredoxin peroxidase 3 25 23 R. conorii AAL02989   1   
              
  Chaperones                     
A22 Chaperonin precursor 3 70 63 P. sativum AAA66365 2 / AV397884 4 8   
A24 Heat shock protein 70 # 100 70 A. albimanus AAC41543 2 / BI874228 4 10   
C2 Luminal binding protein 5 pre. 4 98 74 N. tabacum CAA42660 2 / AV643368 3 7   
C4 Heat shock 70 put. mit. pre.  3 87 70 O. sativa AAO17017   2   
                        
  Calvin Cycle / Carbon Acquisition                     
A8 Carbonic anhydrase  # 47 64 D. salina AAC49378   4   
A12 Carbonic anhydrase  # 35 64 D. salina AAC49378   3   
A14 Carbonic anhydrase  # 60 64 D. salina AAC49378 X      
A17 Rubisco pre. # 55 53 C. moewusii AAA84152  X      
A4 Rubisco large sub. 1 55 53 C. reinhardtii AAA84449 3 / BI726309  6 9   
A15 Rubisco large sub. 1 55 13 bacteria OTI-8 BAA92486 X      
B18 Rubisco large sub. 4 60 52 H. capensis AAK96893 X      
B13 Rubisco activase chl. pre. 2 75 45 C. reinhardtii AAA33091  2 4   
C7 Rubisco activase chl. pre. 2 75 45 C. reinhardtii AAA33091   4   
A9 Phosphoribulokinase pre. 1 45 46 S. oleracea AAA34036 1 / AV392278 6   
A20 Phosphoribulokinase  3 45 42 C. reinhardtii AAA33090 1 / BE453265 1 3   
A11 NADP-Glyceraldehyde-3-phosphate DH 6 42 40 Chlamydo. sp. AB035312    8   
B25 Sedoheptulose-1,7-bisphosphatase 4 42 39 Chlamydo. sp. BAA94305   6   
B8 Dihydroxyacetone kinase 6 76 65 S. pombe AF059204   4   
C3 Dihydroxyacetone/glycerone kinase-like  4 88 64 A. thaliana BAB02871   8   
B29 Triose phosphate isomerase 2 29 23 B. belcheri BAA22631   4   
              
  Starch Biosynthesis / Pentose Phosphate Pathway             
B10 Phosphoglucomutase chl. pre.  73 69 S. tuberosum AJ240053  2 / BE128973 2 10   
B17 6-Phosphogluconate DH decarboxylating 1 64 54 M. sativa AAB41553  2 / BF269268 4 8   
B15 ADP-Glucose pyrophosphorylase small sub. 2 66 55 C. reinhardtii AAF75832   5 10   
B16 ADP-Glucose pyrophosphorylase large sub. 3 65 57 L. esculentum AAC49943   5   
B26 Inorganic pyrophosphatase pre. 2 34 31 C. reinhardtii CAC42762 1 / BM498985 1 8   
C18 Inorganic pyrophosphatase pre. 3 39 31 C. reinhardtii CAC42762   6   
              
  Energy                     
A1 Glucose-6-phosphate 1-DH 6 60 66 D. bioculata CAB52685 X      
A3 Glucose-6-phosphate 1-DH 5 60 66 D. bioculata CAB52685 X      
C13 Plastidic NADP-dependent malate DH 2 58 47 D. bioculata CAC15546   2  3 
B19 Plastidic NADP-dependent malate DH 4 50 47 D. bioculata CAC15546  X      
A2 Dihydrolipoamide S-acetyltransferase   4 60 44 T. elongatus BAC08851   8   
A6 Pyruvate DH E1 alpha sub. 4 50 47 A. thaliana AAB86803   3   
B24 Thiamin biosynthetic enzyme 2 41 37 G. max BAA88227     1 
C17 Adenosine kinase 3 48 38 P. patens CAA75628 1 / BJ172248 1 1   
B23 Ferrodoxin NADP oxidoreductase put. 3 42 43 A. thaliana AAF19753   8   
C15 Ferrodoxin NADP oxidoreductase put. 2 49 43 A. thaliana AAF19753 2 / BG647868 1 4   
C16 Ferrodoxin NADP oxidoreductase put. 3 49 43 A. thaliana AAM65564   1 / BG647868 1 3   
C5 ATP synthase beta chain mit. pre. 2 86 62 C. reinhardtii CAA43808 1 / BE642669 1 4   
C22 ATP synthase delta chain chl. pre. 4 24 24 C. reinhardtii AAB51365    3   
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Table 7  Continued
yrimidine and Amino Acid Biosynthesis                 
lutamine synthetase # 50 42 C. reinhardtii AAB01817  5 7   
lutamine synthetase 3 45 41 C. reinhardtii AAB01818 2 / AV623601 2 3   
arbamoyl phosphate synthetase large chain 3 127 130 A. thaliana AAB67843  3 11   
spartate kinase-homoserine DH put. 3 95 100 A. thaliana BAC43372    3   
-Isopropylmalate synthase put. 4 72 74 A. thaliana AAF26002 2 / AV631505 2 8   
-3-Phosphoglycerate dehydrogenase  3 70 66 A. thaliana BAA20405  2 / BF269268 4   
           
rotein Biosynthesis and Degradation                 
inc metalloprotease 3 112 118 A. thaliana BAB02957  1 / BE249333 2 5   
inc metalloprotease  3 112 118 A. thaliana BAB02957  2 / AV628512 4   
GF-beta receptor interacting homolog 2 42 36 A. thaliana AAC49079   5   
rocessing peptidase put. mit.  2 72 59 A. thaliana AAF14827   7   
6S Proteasome regulatory particle triple-A  2 58 50 O. sativa AB037154 4 / AV620391 4 7   
ranslation elongation factor Tu mit. 5 57 44 R. americana AAD11872   5   
ranslation elongation factor EF-G 4 103 78 G. max X71439  1 / BI727515 2 9   
           
ytoskeleton            
eta tubulin 3 72 50 C. incerta AAB60936 X      
lpha tubulin 2 71 29 Z. mays S39969 X      
lycosilation            
DP-mannose pyrophosphorylase 1 45 40 A. thaliana CAC35355   4   
a+ transpot            
QR alpha sub. 5 79 51 V. cholerae AAF95439    1   
QR alpha sub. 4 77 51 V. cholerae AAF95439    1   
thers                     
TP-binding protein typA 7 92 68 A. thaliana BAB08691     6   
    PMF IDs =  9     
    Mascot EST IDs = 20    
    Mascot Protein IDs = 23   
    MS BLAST(s) Ids=  50  
    MS BLAST(m) Ids=   2 
          
mns: Spot: no. corresponding to 2-D gels; Protein identification: proposed biochemical function of the 
in based on MS analysis and DB searching; FI: fold induction of the spot from changing growth 
itions from 1M to 3M NaCl; OMW: observed molecular weight in kiloDaltons calculated by software X; 
: theoretical molecular weight of the identified protein based on the aligned database sequence; Species: 
 of corresponding retrieved DB sequence; Accession: retrieved DB sequence; PF: Peptide mass 
rprinting, X = positive identification; Ma: no. of peptides positively identified by Mascot by protein DB 
hing; MB: no. of peptides positively identified by scripted or manually interpreted MS BLAST protein 
earching; MT: no. of peptides positively identified by MultiTag protein DB searching; Ma-EST/Ac: no. of 
des positively identified by Mascot EST DB searching / accession number; put. = putative; mit. = 
hondrial; chl. = chloroplast; DH = dehydrogenase; sub. = subunit; pre. = precursor. 
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The complete set of tandem mass spectra from the analysis was further interpreted 
using the MS BLAST sequence-similarity protein identification approach. Amino acid 
sequences were predicted de novo from tandem mass spectra and assembled into modified 
BLAST queries for DB searching, as previously described[62]. MS BLAST identified 50 
proteins, which included all of the proteins identified by Mascot (except one) plus 28 more 
(Table 7).  
Further EST DB searching of all tandem mass spectra with Mascot confirmed the 
protein identifications made in 20 of the cases, using primarily Chlamydomonas reinhardtii 
sequences (Table 7). All spots still unidentified were analyzed by MS BLAST EST DB 
searching; however, this did not contribute to the characterization of any of the unknown 
spots, although the method confirmed the identification of a few proteins already identified 
(data not shown).  
The MT approach for sequence-similarity identification was used as a final attempt 
to identify the remaining unidentified proteins because of its demonstrated enhanced 
sensitivity over MS BLAST (see section 2.2), but this technique was only able to confirm 
an identification made by Mascot and subsequently missed by MS BLAST, and contributed 
only one new identification which relied upon only one peptide alignment. Whereas MS 
BLAST relies upon representing a peptide along its full length, MT is more sensitive when 
low abundance proteins are analyzed and full amino acid sequences can not be discerned, 
rendering MS BLAST ineffective[91].  
 
2.3.3 Dunaliella Proteins Induced in 3M NaCl  
Of the 61 identified proteins, the largest categories are enzymes involved in carbon 
assimilation or mobilization and in production of metabolic energy. Up regulation of four 
major Calvin cycle enzymes (Rubisco, Phosphoribulokinase, NADP Glyceraldehyde 3-P 
DH, Sedoheptulose 1,7 bisphosphatase) and of Rubisco activase, suggest that high salinity 
enhanced CO2 assimilation. The large accumulation of a different form of Rubisco under 
high salt (spot A17) may be an adaptation response for more efficient CO2 assimilation. The 
pronounced induction of plasma membrane-associated carbonic anhydrases is a typical 
response of algae and cyanobacteria to carbon limitation. It has been reported before in 
Dunaliella and proposed to enable the algae to overcome the limitations in CO2 availability 
in hypersaline solutions[155]. 
Up-regulation of two ADP-pyrophosphorylase subunits suggests enhanced starch 
biosynthesis whereas the large accumulation of glucose 6-phosphate dehydrogenase, a key 
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enzyme in starch mobilization and NADPH production, suggests enhanced starch 
degradation and generation of Redox energy for biosynthesis of carbon metabolites.           
Notable enzymes in the category of metabolic energy production, in addition to 
glucose 6-phosphate dehydrogenase, are 2 subunits of pyruvate dehydrogenase 
(dihydrolipoamide S-acyl transferase, pyruvate dehydrogenase E1 alpha subunit), the key 
enzyme in channeling carbon into the citric acid cycle for production of NADH and the 
chloroplastic malate dehydrogenase, which catalyzes translocation of reducing power 
between the chloroplast and the cytoplasm in plant cells. Based on these results we propose 
that high salt induces enhanced starch mobilization, CO2 fixation and Redox energy 
production in order to meet the need for massive glycerol biosynthesis at high salinity 
(Figure 15). This interpretation is consistent with previous indications for synthesis of 
glycerol in Dunaliella from starch and photosynthetic carbon assimilation[156].  
Another group of up-regulated proteins are key enzymes in ammonia assimilation 
(glutamine synthetase) and in biosynthesis of different amino acids. Induction of glutamine 
synthetase in plants usually reflects accumulation of ammonia, either from enhanced 
photorespiration or from enhanced protein degradation (see below). Carbamoyl phosphate 
synthetase, aspartate kinase-homoserine dehydrogenase, 2-isopropyl malate sysnthase and 
3-phosphoglycerate dehydrogenase are key enzymens in the biosynthesis of arginine (and 
pyrimidines), threonine (and methionine, isoleucine), leucine and serine (and cysteine, 
glycine), respectively.  
Various regulatory proteins involved in protein synthesis initiation (eIF3=TGF-beta 
receptor interacting protein), elongation and processing of proteins are up-regulated at 3 M 
NaCl. Related to this is GDP-mannose pyrophosphorylase, involved in protein 
glycosylation. Two other categories include general stress-related proteins in plants: 
antioxidants (Fe superroxide dismutase, thioredoxin peroxidase), involved in oxidative 
stress, and chaperones (chaperonin, HSP-70) involved in protecting proteins under stress 
conditions. NQR alpha is a subunit of the Na+ extrusion complex involved in salinity 
tolerance in bacteria, as will be discussed below.  
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Figure 15  Salt-activated carbon flux in Dunaliella 
 
Here is a metabolic network in Dunaliella that is activated by high salt. Paths in red are activated, some to 
produce an excess of glycerol. (in collaboration with Dr. Adriana Katz) 
 
2.3.4 Salinity Tolerance in Dunaliella 
(in collaboration with Dr. Adriana Katz and Professor Uri Pick) 
 Presented here is the first large-scale proteome analysis of salt up-regulated proteins in a 
lower plant whose genome is largely uncharacterized. Even though the analysis was limited 
mostly to soluble proteins that are up-regulated by no less than 2-fold and eliminated low 
abundance proteins, we were able to identify about 80% of the selected protein components. 
This success is partly due to the fractionation which increased the resolution of up-regulated 
proteins and mostly to the layered mass spectroscopic analysis and in particular the 
sequence-similarity searching algorithm MS BLAST.  
  
 70
 Most proteins identified in the crude plasma membrane fraction were soluble 
proteins derived from the chloroplast or cytoplasm. The contamination of plasma membrane 
preparations with soluble proteins has been observed in many cases and probably results 
from adsorption of soluble proteins that are released during cell lysis. Integral membrane 
proteins were not identified in the crude plasma membrane fraction probably because they 
are under-represented by isoelectic focusing (IEF)[157]. Thylakoid membrane and integral 
plasma membrane proteins are currently being resolved and analyzed by different 
procedures (Pick and Katz). Considering these limitations, it may be expected that the 
overall number of salt up-regulated proteins in Dunaliella is much larger than revealed in 
this study. 
The observation that major Calvin cycle enzymes are up-regulated by high salinity 
in Dunaliella contrast observations in plants and cyanobacteria of suppression of 
photosynthetic carbon assimilation and Calvin cycle enzymes under salt stress[158,159]. 
The typical response of plants to salt/drought stress is inhibition of photosynthesis and 
enhanced photorespiration, which results primarily from CO2 limitation and is predicted to 
consume excess photosynthetically-produced Redox energy. The present results suggest 
that in Dunaliella photosynthesis was not inhibited by high salinity: the accumulation of 
plasma membrane carbonic anhydrases and of major Calvin-cycle enzymes suggests 
compensation for decreased CO2 availability and enhanced CO2 assimilation. Also the up-
regulation of glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, 
ferredoxin NADP oxidoreductase, pyruvate dehydrogenase and NADP malate 
dehydrogenase in Dunaliella suggest enhancement, rather than inhibition, of photosynthetic 
and respiratory Redox energy production and mobilization. These results may have a 
broader significance for identifying rate-limiting steps in carbon metabolism and energy 
production in plants under stress. Up-regulation of distinct key enzymes in the Calvin cycle 
and Redox-energy generation may relieve the general inhibition of photosynthesis under 
stress, which is a major limitation in the ability of plants to cope with salt stress. 
This difference between the response of Dunaliella and higher plants to high salt 
may be explained by the need for massive glycerol biosynthesis in Dunaliella at high 
salinity: at 3M NaCl, the internal glycerol concentration in Dunaliella is close to 5M and it 
constitutes the major carbon pool under these conditions. As shown in Figure 15, these 
results suggest that glycerol is produced from enhanced CO2 assimilation and starch 
degradation channeled through the Calvin cycle to dihydroxyacetonephosphate, which is 
reduced to yield glycerol. Plants and cyanobacteria utilize different osmotic elements 
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(proline, glycine-betaine) that are derived from amino acids. Dunaliella resembles yeast and 
fungi in the utilization of glycerol as an osmotic element[160]. Proteomic analysis of salt-
induced proteins in S. cerevisiae revealed up-regulation of 3 glycerol 
biosynthetic/dissimilation enzymes, including dihydroxyacetone kinase[161], that were 
identified in this work.  
The large increase in glutamine synthetase level in 3M NaCl indicates enhanced 
production of ammonia. The up-regulation of carbamoyl synthase can reflect enhanced 
synthesis of arginine, which is a storage form of assimilated ammonia in plants. Enhanced 
ammonia production may result either from photorespiration or from enhanced protein 
degradation. Although none of these possibilities can be excluded, there are indications 
against enhanced photorespiration. For example, the up-regulation of 3-phosphoglycerate 
dehydrogenase indicated that serine biosynthesis at high salinity in Dunaliella proceeds 
primarily from 3-PGA. High photorespiration activity produces glyoxalate which serves as 
an alternative substrate for production of serine and suppresses biosynthesis from 3-PGA. 
Also the indications for high CO2 assimilation activity and the massive production of 
glycerol are inconsistent with enhanced photorespiration. It seems more likely that the 
upregulation of glutamine synthetase reflects ammonia production from enhanced protein 
degradation.  
Conversely, the up-regulation of key enzymes in amino acid biosynthesis suggests a 
need for enhanced synthesis of new proteins. Another indication for enhanced biosynthesis 
and degradation of proteins at high salinity is the up-regulation of several regulatory factors 
in protein translation initiation and elongation and protein processing enzymes. Of 
particular interest is the dual-function eukaryotic initiation factor eIF3=TGF beta-receptor 
interacting protein (spot A10). Homologs of this protein in mammals and in plants interact 
with plasma membrane receptors and as such are part of a signal-transduction pathway in 
response to external stimuli[162,163]. A fission yeast homologue, of this protein Sum-1, is 
part of protein translation initiation complex 3 and was shown to be re-localized under salt 
or heat stress into distinct cytoplasmic domains[164]. Also the two mitochondrial 
translation elongation factors, EF-G and EF-Tu, may have dual functions: in addition to 
their established roles in protein biosynthesis, bacterial homologues of both proteins have 
chaperone properties and were proposed to protect proteins against mis-folding under 
stress[165,166]. The mitochondrial processing peptidase, zinc metaloproteases, and GDP-
manose pyrophosphorylase are involved in processing and glycosylation of proteins. It may 
be noted that a major plasma membrane salt-induced proteins in Dunaliella, a triplicated 
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transferrin-like protein, is heavily glycosylated [167,168]. Conversely, the up-regulation of 
a 26S proteasome regulatory subunit suggests enhanced protein degradation at high salinity. 
The overall picture emerging from these results is of a dynamic reorganization of protein 
composition in different cellular compartments, by synthesis and processing of novel 
proteins as well as by massive degradation of other proteins.  
Another particularly interesting up-regulated protein is the NQR alpha subunit 
homolog, a component of a bacterial Redox-driven Na+ extrusion system[169]. It has 
recently been reported evidence for Redox-driven Na+ extrusion system in Dunaliella[170]. 
The identification of a homologous protein to the bacterial system provides a tool for 
identification and cloning of this unique Na+ transport system that so far has not been 
identified in eukaryotes. 
In summary, these results suggest that the response of the halotolerant alga 
Dunaliella to high salinity involves up-regulation of different enzymes and metabolic 
pathways, some of which differing from higher plants, such as carbon assimilation and 
mobilization for glycerol biosynthesis and Redox-drived Na+ extrusion, others common to 
plants and related organisms (chaperones, antioxidative enzymes), and others whose 
relationship to salt stress in plants has not yet been clarified. The latter include the factors 
regulating protein biosynthesis, processing and degradation, which may have cardinal 
importance in adaptation to high salinity. 
 
2.3.5 Cross-Species Protein Identification Specificity of Mascot and MS BLAST  
The Mascot software may detect a match as being significant when one or multiple MS/MS 
spectra from the analyzed peptides are correlated with a DB sequence from a related 
species, taking into consideration certain statistical issues, such as the goodness of fit 
between the observed and theoretically predicted fragment ions, mass accuracy, and the size 
of the DB. Mascot can generally align a few (one or two) peptides from proteins from 
organisms with unsequenced genomes with DB sequences from related organisms; for 
instance, in this study of Dunaliella salina, the majority of Mascot identifications were 
made by using reference sequences from Chlamydomonas sp.  
However, Mascot is prone to produce false positives (like every protein 
identification method associated with MS); this usually occurs with the correlation of one or 
two spectra/peptides to a DB entry. A false positive occurs when the DB sequence 
recognized by Mascot correlation methods and scoring rules doesn’t truly represent the 
peptide that was fragmented to produce the resulting spectrum. In these cases, by 
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substituting isobaric amino acid combinations within the length of a peptide sequence, the 
sequence will mistakenly indicate an unrelated protein; a false positive. For instance, 
Mascot recognized the peptide YPIDWFK and a related miscleavage form, YPIDWFKK 
(1095.575), putting the protein identification well above the scoring threshold. However, 
upon MS BLAST analysis of the same data set, two other peptides and the isobaric peptide 
sequence YPLVSDFKK (1095.596) were recognized as aligning to a different protein entry 
that shared no significant sequence similarity with the Mascot identification (Figure 16). 
Furthermore, the complete fragment ion series could be read for this peptide (and its fully 
cleaved product, YPLVSDFK) in the MS BLAST identification, the entry had the 
appropriate predicted molecular weight, and a homologue existed in Chlamydomonas 
reinhardtii.  
Upon close manual interpretation, that is, by overlaying of the retrieved sequence on 
to the spectrum and examining the closeness of fit of the predicted fragment ions, the high 
sensitivity, resolution and mass accuracy of Q(q)TOF MS enables the discernment of 
inconsistent mass accuracy errors and the inspection of the absence of usually intense 
fragment ions (such as, the b-2 ion, the a-2 ion, or b series or y series ions, or immonium 
ions), indicating the likelihood of a false positive identification. By extending the sequence 
coverage of the DB entry with the other tandem mass spectra, ambiguous sequences can be 
correlated with more evidence. By inspecting the data in this way, false positives can be 
minimized, as it has been done in this study. 
The MS BLAST approach has been demonstrated here to produce higher sequence 
coverage than Mascot by aligning more peptides in an error-tolerant sequence-similarity 
manner, increasing the confidence of protein identifications by MS. MS BLAST recognized 
266 peptides in total from tandem mass spectra (averaging 5.32 peptides per identification, 
range 1-11) whereas Mascot was able to align only 60 peptides in total to DB entries 
(averaging 2.6 peptides per identification, range 1-6). In 19 cases, MS BLAST extended 
Mascot sequence coverage (i.e. from 1 to 8 peptides aligned); MS BLAST averaged 6 
peptides per identification for this group. In 28 additional cases, MS BLAST made 
identifications where Mascot was unable to produce any significant alignments, averaging 
4.4 peptide alignments per identification. EST DB searching with Mascot averaged 1.75 
peptides per identification in 20 cases.  
In this manner confident cross-species protein identifications were determined. This 
data further demonstrates the fact that all proteins identified in proteomics are assigned with 
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certain confidence levels, with some protein assignments having higher confidence levels 
than others.   
 
 
 
 
Figure 16 Mascot false positive identification. 
 
A doubly-charged peptide ion of precursor mass m/z 548.80 was fragmented on a Q(q)TOF mass spectrometer; 
the acquired m/z range was from 100 to 1200 Thomsons (above). Mascot matched the amino acid sequence 
YPIDWFKK (1095.575 amu) from a protein DB to the tandem mass spectrum above. However, de novo 
sequencing and MS BLAST analysis of the same mass spectrum recognized the near isobaric peptide sequence 
YPLVSDFKK (1095.596 amu). Both sequences matched all of the same y-ions (fragments which retain the C-
terminus of the peptide) except for three discrepancies (positions are shown in spectra 1-3 above, m/z 536-540, 
605-610, 623-627, respectively). The sequence retrieved by Mascot required an ion match at the Red line in 
spectrum 2 to have a full y-ion series. The sequence retrieved by MS BLAST required an ion match at the Red 
lines in spectrum 1 and 3 to have a full y-ion series.   
 
 
 
2.3.6 Assigning Biochemical Function to Proteins based on Sequence Alignments 
Extending sequence coverage may help exclude false positive functional assignments based 
on sequence identity, but only to a certain degree. Rost has demonstrated using 
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bioinformatics that proteins with high sequence similarity (70-90%) can have divergent 
biochemical functions[171].  To overcome this problem for sequence-similarity protein 
identification, the analyzed proteins in proteomics need to be found in specific functional 
contexts. For example, here we attempted to identify soluble proteins induced under 
specific stress conditions. The experimental context used to recognize a set of proteins in 
proteomics already puts the proteins to be identified in a functional setting, thus imposing 
certain criteria on the character of most of those identifications; i.e. kinases, ribosomal, 
glycolytic, etc. For example, if we were to identify one of the Dunaliella proteins as a 
human histone (and if we did not question the integrity of the biochemical preparation), we 
would likely doubt the validity of such an identification, even if extensive sequence-
similarity was determined. In the case demonstrated here, the multiple proteins identified 
were recognized to fit into coherent metabolic pathways and biochemical patterns, thus 
further suggesting that such sequence-similarity identifications likely correspond to the 
proposed biochemical function of the protein.  
 
2.3.7 Sequence-Similarity Protein Identification in Plant Proteomics 
The above study demonstrated that sequence-similarity protein identification techniques by 
MS could identify more than twice as many proteins recognized by the conventional 
software, subsequently greatly enhancing the proteome analysis in the alga Dunaliella 
salina. The DB searching sensitivity of MS BLAST was demonstrated to be a significant 
advantage over Mascot because of the BLAST algorithm’s ability to perform true sequence-
similarity alignments, and in no cases did these alignments rely upon precursor mass 
correlation or the exact matching of predicted peptide fragment ions with observed ions. 
Furthermore, this capability allows MS BLAST to extend the sequence coverage capable of 
conventional methods, thus utilizing a greater proportion of mass spectra for protein 
identification, and increasing the confidence of identifications. One disadvantage of MS 
BLAST is the requirement that amino acid sequences need to be predicted from peptide 
tandem mass spectra, either manually or automatically, thus requiring a certain abundance 
of protein and a certain level of spectra quality.  
Even though these techniques were used with nanoelectrospray MS for the above 
study, the MS BLAST and MT sequence-similarity DB searching methods can be applied to 
data generated by different MS platforms (reviewed in section 1.1.3). Recently, the method 
has been applied with MALDI TOF-TOF MS[172]. Similarly, MT may be applied to all 
MS data where peptide sequence tags can be determined from tandem mass spectra (see 
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section 2.5.2). However, these methods are most effective in the analysis of gel separated 
proteins and due to statistical considerations they most likely will not be able to be utilized 
with shotgun proteomics methods such as MudPIT[39]. 
 With these methods and future related developments, the proteomes of plants with 
unsequenced genomes will be more amenable for characterization by high-throughput MS 
techniques. Not only will more conserved proteins be able to be identified in distantly 
related plant species from those with sequenced genomes, but also more divergent 
homologous proteins will be able to be identified from those species that are closely related 
to organisms with sequenced genomes, such as maize, wheat, and barley, using the rice 
genomic sequences. Using these methods for protein identification, immediate, rapid and 
effective proteome analysis will be possible in plant biochemistry and physiology in many 
species, without having to wait for the completion of future genomic sequencing in many 
cases.     
 
2.4 MS BLAST Specificity and Phylogenetic Considerations for Future 
Genomic Sequencing 
2.4.1 Calculation of MS BLAST Specifity and Phylogenetic Reach of Protein 
Identification Using Available Resources. 
To estimate the success of proteome characterization for a selection of organisms with 
unsequenced genomes, we calculated the specificity of MS BLAST to identify homologous 
proteins. The success rate of MS BLAST searches was correlated to the phylogenetic 
distance of the organism under study to the next closest organism with a fully sequenced 
genome. With the analysis of 10 peptides (each 10 amino acids in length, with two 
undetermined residues placed at randomly chosen position in their sequence), MS BLAST 
can successfully identify proteins down to a limit of 65% identity. Taking into consideration 
eight species with sequenced genomes, we propose groups of species where sequence-
similarity methods will be effective (Figure 18). With these developments, functional 
proteomics in important model species with unsequenced genomes has the potential to be 
advanced by MS and sequence-similarity DB searching. 
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Figure 17  Predicted success of proteomics in organisms with unsequenced genomes 
Three partial phylogenetic trees of major subkingdoms branch from a phylogenetic tree of all living organisms. 
Phylogenetic analysis was used to estimate the success of proteome characterization by mass spectrometry and 
sequence-similarity database searching, based on the specificity of the MS BLAST to identify homologous 
proteins. To estimate the success of MS BLAST searches, queries comprised of 8 peptides sequences were 
used, 10 amino acids in length and with 2 errors in each peptide to simulate ambiguities in spectrum 
interpretation. Organisms in red have sequenced genomes. Color code is based on the distance between species 
and corresponding protein identification coverage of the proteome by MS BLAST; light green: >90% 
coverage; middle green: 30-50% coverage; dark green: up to 30% coverage. (in collaboration with Dr. Bianca 
Habermann) 
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2.4.2 Genomic Sequencing and Proteomics 
Currently, there is a substantial debate over which organisms’ genomes deserve to be 
sequenced next[173,174]. A recent conference sponsored by the National Human Genome 
Research Institute focused on the direction of genomic sequencing and established criteria 
for the selection of the next organisms to be sequenced. The criteria include the ability to 
improve human health, the scientific utility of the new data, and technical considerations. 
One suggestion at the conference was to sequence the genome of an organism from each of 
the major branches of life to better understand the evolution of traits[173]. As already 
mentioned, the ability to identify proteins depends on DB content, meaning this genomic 
sequencing proposal may also be extremely beneficial for the proteomics of the organisms 
with unsequenced genomes in these diverse branches, in light of cross-species protein 
identification by MS.  
With over 1.7 million described species, and potentially as many as 10 million 
species in the biosphere, it is evident that the research community will not be able to 
sequence the genome of every species. Many biological researchers investigating proteomes 
have already experienced the lack of genomic resources as an inability to identify proteins 
by MS. For example, proteomics studies in maize, an economically important organism, 
have been compromised due to the lack of DB resources and an inability to use available 
DB resources effectively[78]. However, plant scientists have begun to realize the limitations 
of non-error-tolerant methods of protein identification and now see the prospects of 
sequence-similarity methods to contribute to proteomics[78,148].   
Yet for organisms distantly related to ones with sequenced genomes, even protein 
identification by sequence-similarity methods will be ineffective in many cases because 
sequences still will not exist in databases that have significant identity to those proteins 
studied.  For example, whereas many proteins in mammals will have sequence similarity to 
human, the more diverse classes of proteins in distantly related mammals would be unable 
to be identified (any protein below ~50% identity).  In addition, as percent identity 
decreases between orthologs, it is likely that the divergent protein will take on a new 
function.  Without the genomic sequencing of organisms in these distant phylogenetic 
regions, which could fill the gap between available genomic sequences and proteins from 
organisms with unsequenced genomes, many analyzed proteins will go unidentified because 
of a continuing deficiency of genomic sequence resources. 
As genomic sequences become available to the public in the form of annotated DB 
entries, these sequences are immediately used in proteomics to identify isolated gene 
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products.  Historically, with the completion of a genomic sequencing project, those 
sequences were utilized to identify proteins from the organism with the newly sequenced 
genome.  Since MS relies upon databases to make protein identifications, it is evident that 
as more genomic sequences are produced, it will be possible to identify more proteins.  This 
has been the case since the inception of proteomics.   
However, in addition, every sequenced genome provides a resource that enables 
researchers to identify homologous proteins in many organisms.  Consider the impact made 
by the complete genomic sequencing of Arabidopsis thaliana upon plant proteomics (Table 
8).  The Arabidopsis genomic sequences provide a resource for the identification of proteins 
from Arabidopsis itself and many different species of plants as well.  With the application 
of MS and sequence-similarity methods, a single sequenced genome will enable the 
identification of more proteins from the proteomes of organisms with unsequenced genomes 
than by the use of methods that are only able to identify proteins of high homology to DB 
entries.  For example, all cross-species identifications in the study of the maize proteome by 
Chang et al. could have been accomplished using DB entries from the Arabidopsis genome 
and sequence similarity searches (Table 9) Even though Chang et al. identified maize 
proteins using DB entries from many different plants, this data only underscores the fact 
that many proteins are highly homologous in related organisms, and sequence-similarity 
searches will likely be successful in making proteomics a reality in a significant number of 
organisms with unsequenced genomes.   
The expanding organismal scope of proteomics depends upon the creation of 
software tools for sequence-similarity searching and related methods that couple MS with 
bioinformatics, as discussed above, and the sequencing of genomes.  In this context, species 
representative of diverse phylogenetic lineages must have their genomes sequenced.  More 
specifically, the proteomics of organisms with unsequenced genomes is probably focused to 
certain phylogenetic branches, which could be better represented by genomic sequencing, 
giving a broad resource for many independent researchers.  These sequenced genomes can 
represent many phylogenetically related organisms depending on the nucleotide substitution 
rate in those lineages and the ability to annotate future genomic sequences[175,176].  
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Table 8  Sequencing of the Arabidopsis genome and its effects in proteomics. 
Year 
Genomics  
Development  Proteomics   Ref. Organisms in the ID of Proteins MS MS/MS SSS Citation
2000 Arabidopsis thaliana Papaver somniferum ARABIDOPSIS (31), P. sativum(6), Glycine max(6), X  X** [81] 
   Nicotiana tabacum(3), Solanum tuberosum(3),      
   Oryza sativa(3), Vitis vinifera(3),      
   Protea neriifolia(2), Lavatera thuringiaca(2),      
   Brassica oleracea(2), Fritillaria agrestis(1),      
   Z. mays(1), Brassica juncea(1), Datisca glomerata(1),      
   Hordeum vulgare(1), S. cerevisiae(1),       
   S. oleracea(1), Linum usitatissimum(1),     
   Citris paradisi(1), Catharanthus roseus(1),     
   Schizosaccharomyces pombe(1), Batis maritima(1),     
   Thermotoga maritima(1), Alcaligenes entrophus(1),    
   Amycolatopsis mediteranei(1), Malus domestica(1),     
   Mesmryanthemum crystallinum(1)     
  Zea mays ARABIDOPSIS (2), B. vulgaris(2),  B. napus(2), G. max(2), X   [77] 
   C.roseus(4), O. sativa(3), N. tabacum(3), M. sativa(3),     
   H. vulgare(2), C. reinhardtii(1)     
  Pisum sativum ARABIDOPSIS (8), Z. mays(3), G. max(3), O. sativa(2), X X  [79] 
   Lycopersicum esculentum(2), Nicotiana sylvestris(1),     
   H. vulgare(1), Carica papaya(1), Helianthus annuus(1),     
   Onobrychis vicifolia(1), Sesbania rostrata(1),      
   Physcomitrella patens(1),       
  A. thaliana ARABIDOPSIS (33), Z. mays(3) X X  [82] 
  Z. mays ARABIDOPSIS (14),O. sativa (22), Triticum aestivum(15),  X   [78] 
   P. sativum(5),H. vulgare(5), S. oleracea(5),     
   Cucumis sativus(4), N. tabacum(3), S. tuberosum(2)    
   Picea rubens(1), Secale cereale(1), Populus nigra(1),    
   Schismocarpus matudai(1)     
2001  T. bruei   ARABIDOPSIS , Mouse, D. melano, E. histoly, C. elegans,   X X [60] 
   O. sativa, S. cerevisiae, and others(9)     
  X. laevis *ARABIDOPSIS (1) *B. taurus(1) , *Mouse (1), *Rat (1), X X [85] 
    *Human (1),      
 
Organisms in the column “Developments in Proteomics” had proteins identified by cross-species identification.  
Organisms in the column “Ref. Organisms…” contributed reference database entries used in the identification 
of proteins from organisms in the previous column, with the number of proteins following reference organism.  
“MS” designates that proteins were identified peptide mass mapping, “MS/MS” by tandem mass spectrometry, 
and “SSS” by sequence similarity searches.  *Multiple alignments are made to different species from the 
analysis of a single protein. **Peptides were sequenced by Edman degradation. 
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Table 9 Arabidopsis homologues to database references used in maize protein identification[77] 
Accession No. Accession No.  Identity 
X89451 B. napus AAL32658 Arabidopsis 89% 
Z97178 B. vulgaris AAK32918 Arabidopsis 89% 
X83499 C. roseus AAK82464 Arabidopsis 88% 
U40212 C.reinhardtii AAL32658 Arabidopsis 72% 
U53418 G. max BAB02581 Arabidopsis 89% 
P37228 G. max O82399 Arabidopsis 77% 
X91347 H. vulgare P57751 Arabidopsis 77% 
AF020271 M. sativa BAA97065 Arabidopsis 80% 
X77944 N. tabacum AAK73989 Arabidopsis 88% 
U38199 O. sativa T48154 Arabidopsis 83% 
D67043 O. sativa AAA79369 Arabidopsis 83% 
Z26867 O. sativa AAG10639 Arabidopsis 88% 
 
Protein sequences from Organisms in the left column were used to identify maize proteins by peptide mass 
mapping.  Arabidopsis homologues exist to all maize proteins that were cross-species identified. BLASTP 
searches were performed at NCBI to create the table above. 
 
With the complete sequencing of the pufferfish genome, we can predict that studies 
into the proteomes of other fishes will capitalize on these sequence resources by using 
sequence-similarity search methods[12]. Once a bird’s genome or reptile’s genome is 
sequenced, we can expect to see developments in the proteomics of related organisms.  For 
the timely expansion of the organismal scope of proteomics, the selection of closely related 
organisms for genomic sequencing is not an optimized use of available resources.  From a 
proteomics perspective, it makes no difference whether the human or the chimpanzee has its 
genome sequenced, because only one of the organisms needs to have its genome sequenced 
for the successful proteomics of both using the discussed analytical methods. 
With the use of MS and emerging bioinformatic techniques, proteins could 
potentially be identified from any organism depending on the availability of diverse 
genomic sequences and the annotation of those sequences.  As many biologists are without 
protein identification support for their research, we can directly conclude from these 
developments that where proteomics studies are desired, genomics should utilize its efforts 
on organisms phylogenetically situated to positively affect the proteomics of their 
phylogenetic neighbors.  The future of protein identifications by MS and the efforts of 
biological scientists involved in proteomics of organisms with unsequenced genomes 
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depends to a large degree on the sequencing of the genomes from underrepresented classes 
and distantly related organisms in accordance with the findings of molecular systematics.  
 
2.5 Analytical Strategies in Proteomics 
2.5.1 Analytical Strategies 
Protein identification by MS and sequence DB searching was established in 1993, and since 
that time the proteomics community has witnessed a proliferation of analytical strategies for 
protein identification. Analytical strategies are composed of three components: mass 
spectrometry platforms, spectra-database sequence correlation methods, and sequence 
databases. To extend protein identification capabilities, as well as to advance the efficacy of 
protein identification in organisms with unsequenced genomes, a number of recent 
developments are pointing to new analytical strategies to interrogate proteomes. Specific 
types of mass spectrometers produce spectra of varying quality, and alternate interpretation 
methods are suited for specific types of spectra. When a specific mass spectrometry 
platform is combined with a specific correlation method and a specific type of database, 
this combination may be more or less effective for protein identification than a different 
combination. Here, to discuss these relationships, we will designate specific analytical 
strategies by the annotation “mass spectrometry platform”(where “MS/MS” means any 
tandem MS method, unless otherwise named)—“spectra-DB sequence correlation 
method”–“sequence database.” To enhance protein identification ability, a number of 
combinations must be developed, compared, and employed simultaneously in proteome 
analysis. Here this complexity is attempted to be systematically described and potential new 
strategies for protein identification are recognized. Multiple strategies are now applied 
simultaneously to increase sensitivity, throughout, and reliability of the characterization of 
proteomes. Now, by assessing the complexity of the interplay of MS, bioinformatics and 
sequence databases, we can begin to predict future approaches and challenges in the 
development of proteomics. 
 
2.5.2 Spectra-Sequence Correlation Methods and Analytical Strategies 
Mass spectra are correlated with DB sequences primarily in three ways: the mass pattern, 
the amino acid sequence, and the sequence tag (Figure 18). These three methods derive 
information of different qualities from peptide MS/MS, and they each suit the interpretation 
of spectra (more or less effectively) depending on the spectra’s signal-to-noise, mass 
accuracy and resolution. Furthermore, each of the different methods has distinct capabilities 
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to identify analyzed peptides whose sequences share only partial identity with DB 
sequences. 
Mass patterns (composed of lists of m/z values of detected peaks along with the 
corresponding peak intensities) are used in two types of MS analysis: PMF and MS/MS. In 
PMF, masses of intact peptides are determined and are used for DB searches. Historically, 
mass patterns derived from peptide mass fingerprints were first used to search protein 
sequence databases (PMF-mass pattern-Protein DB)[177-180] (Figure 19)(Table 10). 
Observed peptide masses are compared with peptide masses calculated from the in silico 
digestion of protein DB sequences with trypsin, and resulting matches are scored 
accordingly. In these softwares, mostly mass values have been used, but now there are 
attempts to incorporate peak intensities to improve the specificity of the 
identifications[102,181,182]. When analyzed peptide sequences deviate away from the 
identity of corresponding sequences in DB entries, either because of amino acid substitution 
or post-translational modifications, the probability of successful identification by this 
method diminishes[13], and MS/MS must be employed. 
A second common analytical strategy correlates MS/MS spectra through mass 
patterns with protein DB sequences (MS/MS-mass pattern-Protein DB)[15,102,147,187-
189]. In these cases, observed masses of peptide precursors and masses and intensities of 
their fragment ions are compared with theoretical peptide masses and fragments derived 
from sequence databases with the application of particular enzyme specificity and peptide 
fragmentation rules. The method of scoring of the similarity between MS/MS spectrum and 
DB sequence employs certain peptide fragmentation models, and those models are 
instrument-dependent. To this end, DB searching programs usually allow the specification 
of instrument type. MS/MS spectra with higher mass accuracy will be able to interrogate 
databases more specifically, increasing the probability of identification with fewer 
peptides[15]. Furthermore, MS/MS spectra with high signal-to-noise will give best results, 
as true peptide fragment ions won’t be obscured by background peaks in spectra. Mass 
pattern methods are currently more diverse and have experienced a greater attention in the 
proteomics community than other protein identification methods. The correlation of mass 
patterns with DB sequences also have some “error-tolerant” capabilities that withstand 
amino acid substitutions between those peptides observed and sequences present in a 
DB[15,103]. In addition to protein DB interrogation, spectra can be correlated through mass 
patterns with EST databases (MS/MS-mass pattern-EST DB)[15,102,147,190] and more 
recently with genomic databases (MS/MS-mass pattern-Genomic DB)[184,190] (Figure 
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19). Besides using complete mass patterns for protein identification, the recently developed 
“peptide end sequencing” makes use of N- and C-terminal peptide fragment ions detected in 
the low m/z region, along with a parent mass, for the identification of low abundance 
proteins[191,192]. However, if multiple non-isobaric amino acids substitutions occur within 
individual peptides or if unknown multiple post-translational modifications exist, then the 
probability decreases that the protein will be identified by these methods. In these cases, a 
different method of spectra interpretation is employed.  
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Figure 18  Representative Information from the Mass Spectrum in Proteomics. 
Mass spectra can be represented by primarily three types of information for their correlation with DB 
sequences. Mass patterns are composed of lists of m/z values of detected peaks and corresponding peak 
intensities (partial list shown above/right). Amino acid sequences are derived from spectra considering precise 
mass differences in ion series, and annotated in the form of series of amino acid symbols (KVLQV…).  
Sequence tags consist of partial amino acid sequences combined with two mass values which lock the sequence 
within the length of a peptide, and a parent mass (the sequence tag for the above spectrum is 
(815.44)VFE(1190.62), peptide mass 1460.72. 
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Figure 19  Strategy Network 
Analytical strategies are composed of three components: mass spectrometry platforms, spectra-sequence 
correlation methods, and sequence databases, which can be read left to right, in the scheme above. Arrows 
show the interaction of mass spectra with representation methods (mass pattern, amino acid sequences, 
sequence tags)(see Figure 18) and nucleotide or amino acid databases (protein, EST, genomic). Arrows 
represent robust and less established interactions equally, despite practical limitations to some. 
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 Table 10  Analytical Strategies 
Analytical Strategy Ref. 
MS  
PMF-mass pattern-Protein DB [177] 
PMF-mass pattern-EST DB [102] 
PSD-mass pattern-Protein DB [22] 
PSD-amino acids-Protein DB [183] 
MS/MS  
MS/MS-mass pattern-Protein DB [147] 
MS/MS-mass pattern-EST DB [147] 
MS/MS-mass pattern-Genomic DB [184] 
MALDI-Q(q)TOF-amino acids-Protein DB [62] 
ESI-Q(q)TOF-amino acids-Protein DB [85] 
ESI-TQ-amino acids-Protein DB [85] 
LC-Q(q)TOF-amino acids-Protein DB [63] 
ESI-Ion Trap-amino acids-Protein DB [185] 
MS/MS-amino acids-EST DB * 
MS/MS-amino acids-Genomic DB * 
MS/MS-sequence tag-Protein DB [86] 
LC-Ion Trap-sequence tag-Protein DB [186] 
MS/MS-sequence tag-EST DB [88] 
MS/MS-sequence tag-Genomic DB [82] 
 
Representative analytical strategies are listed above. Analytical strategies are represented by the annotation 
“mass spectrometry platform”(where “MS/MS” means any tandem MS method, unless otherwise named)—
“spectra-sequence correlation method”–“sequence database.” Researchers who contributed to the development 
of these strategies are cited in the column on the right. *These strategies are currently established in house and 
are under development.  
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Amino acid sequences enable spectra interpretation for the identification of proteins 
that are homologous to DB sequences despite having no peptides of identical precursor 
mass with those theoretically predicted from DB entries (as required by mass pattern 
searches). In this analytical strategy, amino acid sequences produced from MS/MS spectra 
can be correlated with protein DB sequences (MS/MS-amino acids-Protein DB)[57,61,62]. 
Amino acid sequences can be produced de novo from MS/MS spectra of peptides primarily 
by two methods: via chemical modification of peptide N- or C-termini or by direct 
computer-assisted interpretation of spectra by sequence prediction algorithms (see section 
1.1.4). Chemical modification methods demand relatively large sample quantities, are 
manually laborious, and ultimately obscure spectra for parallel mass pattern interpretation. 
However, sequence prediction algorithms rapidly generate putative amino acid sequences, 
although often multiple degenerate sequences are predicted with similar statistical 
confidence. To utilize this information, numerous peptide sequences from multiple 
fragmented peptides must be compiled in a query for a sequence-similarity DB search. This 
has been accomplished in dedicated softwares based on FASTA[59] and BLAST[58] 
sequence homology searching algorithms. Mass spectrometry driven BLAST (MS BLAST) 
is one example of this type of strategy[62].  
Amino acid sequence-based interpretation methods are also flexible for the 
development of alternate analytical strategies (Figure 19). In one proteome analysis, MS 
BLAST was employed to correlate MALDI-Q(q)TOF spectra with protein DB sequences 
(MALDI-Q(q)TOF-amino acids-Protein DB)[62]. However, this is just one strategy among 
other possible paths considering available MSPs, databases, and developments in high-
throughput spectra processing and MS BLAST DB searching capabilities. NanoESI-
QqTOF-amino acids-Protein DB and NanoESI-TQ-amino acids-Protein DB[85], as well as 
LC-QqTOF-amino acids-Protein DB[63], are other options for sequence-similarity 
identification depending on available instrumentation (Table 10). Furthermore, peptide 
sequence can be generated de novo from LC-ion trap mass spectra and used for protein DB 
interrogation (LC-Ion Trap-amino acids-Protein DB)[185,193]. In addition, MS/MS-amino 
acids-EST DB and MS/MS-amino acids-Genomic DB are other possible DB searching 
strategies that could also be employed for protein identification with amino acid sequences 
(currently both approaches are operating in house) (Table 10). All of these strategies enable 
new capabilities for protein identification; however, their efficiency is limited when 
sequence prediction fails.  
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Sequence tags enable spectra interpretation for the identification of proteins from 
low intensity spectra or where background chemical noise interferes with full-length amino 
acid sequence determination. Sequence tags consist of a few (2-4) determined amino acids, 
along with two mass values, which lock the sequence stretch within the length of the 
peptide[86] (Figure 18), effectively combining mass data with sequence data. This requires 
that only one section of a complete mass spectrum be interpreted correctly by manual 
inspection. Sequence tags can be employed to identify proteins by correlating MS/MS 
spectra (of preferably high mass accuracy[15]) with protein (MS/MS-sequence tags-Protein 
DB)[87], EST (MS/MS-sequence tags-EST DB)[88], or genomic DB sequences (MS/MS-
sequence tags-Genomic DB)[82] (Figure 17). However, it is rather difficult to assemble 
sequence tags from MALDI-TOF/TOF and MALDI-Q(q)TOF spectra[194], mostly because 
prominent y- or b- fragment ion series often cannot be determined unambiguously[25].  
Error-tolerant sequence tags enable the identification of proteins that are 
homologous to DB entries[91]. The recently developed MT software correlates multiple 
(often partial) sequence tags with individual DB entries, whereas previous identification 
techniques using sequence tags rely upon the correlation of individual spectra to DB entries 
alone. The MT approach is similar to approaches with mass patterns[15,102,147] or amino 
acid sequences[57,61,62] that rely upon information from multiple spectra to increase the 
confidence of protein identifications. The MT approach was also extended to EST DB 
searching, and in the future, a MT approach could greatly facilitate genomic DB searches 
with sequence tags. 
The correlation of mass patterns, amino acid sequences, and sequences tags with 
DB sequences all have their own unique evaluation schemes to discriminate correct from 
false positive protein identifications. Mass pattern identification methods primarily score 
the quality of a tandem mass spectrum’s fit to a predicted model spectrum, while taking into 
consideration other DB search parameters (i.e. SEQUEST[147], Mascot[102], Protein 
Prospector[15], Scope[187], Sonar MS/MS[188], ProbID[189]). Protein identifications 
made using amino acid sequences are evaluated by the significance of the alignment of a 
sequence query to a DB sequence and the probability of that alignment occurring in a DB of 
a specific size (i.e. CIDentify[57], MS BLAST[62], and FASTS[61]). In the evaluation of 
multiple sequence tags (MT), the probability that such a set of sequence tags align at 
random to a DB entry (within a DB of a particular size and at a particular mass accuracy) 
provides a measure of confidence of the identification.  
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The existence of multiple scoring schemes for the determination of the significance 
of spectra-sequence alignments raises the question of whether proteins identified by one 
method are considered positive identifications by another similar method (for instance, two 
mass pattern methods, or two amino acid sequence methods), which could ultimately 
compromise the certainty of proteome characterization. A solution to alternate scoring 
systems can be provided with the implementation of algorithms that calculate probabilities 
that the spectra acquired derive from specific known sequences, rather than their similarity 
occurs at random[195]. Another possibility is to develop empirical statistical models based 
on search results to assess the validity of protein identifications by MS and DB 
searches[196]. This approach suggests that in the future statistical data interpretation 
methods can be applied to search results acquired by different MSPs and individual 
softwares[196].  
 
2.5.3 Bridging the Gap: A Network of Strategies 
The character of various types of MS/MS spectra directly determines the operation of 
spectra-DB sequence correlation methods (mass lists, amino acid sequences, and sequences 
tags) and different methods enable unequal abilities to interrogate databases (protein, EST, 
and genomic). Alternate MSPs, spectra-DB sequence correlation methods, and databases 
can be combined yielding varying degrees of effectiveness for protein identification, and 
new analytical strategies are rapidly creating novel ties between different types of spectra 
through the three discussed interpretation mechanisms (Figure 19). Each particular 
proteome analysis will require a different strategy or strategies to successfully identify 
proteins at a high throughput depending on the MSPs at hand, the proteins’ abundance, the 
quality of experimental mass spectra, and the availability of species-specific DB sequences, 
as well as the DB type or types employed. This applies both to the proteomics of organisms 
with sequence resources as well as those species with unsequenced genomes. 
 Simultaneously applying multiple analytical strategies has enabled the most 
effective approaches in the analysis of complex protein mixtures by increasing sensitivity, 
throughout, and reliability of the characterization of proteomes. In 1996, multiple strategies 
began to be employed simultaneously with the application of PMF-mass pattern-Protein DB 
and MS/MS-mass pattern-Protein DB together in one study (Table 11)[197]. Today, 
multiple strategies are employed on a regular basis for high-throughput proteomics. In the 
recent characterization of the human nucleolus, five strategies (PMF-mass pattern-Protein 
DB, MS/MS-mass pattern-Protein DB, NanoESI-Q(q)TOF-sequence tags-Protein DB, 
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NanoESI-Q(q)TOF-sequence tags-EST DB, and NanoESI-Q(q)TOF-sequence tags-
Genomic DB) were all employed simultaneously[87]. In addition, in this study, multiple 
protein (nrdb and IPI) and genomic (phases 0-3 of the uncompleted human genome 
sequence) databases were interrogated, adding addition reference sequences to facilitate 
protein identification.  
The effective characterization of proteomes from organisms with unsequenced 
genomes relies upon the use of multiple analytical strategies as well. The proteome of maize 
leaves was analyzed using two strategies, PMF-mass pattern-Protein DB and PMF-mass 
pattern-EST DB[78]. However, using only these two strategies enabled the identification of 
216 spots out of 300 analyzed from 2-D gels. The authors recognized the importance of 
MS/MS methods (perhaps homology-based) for further studies to be more comprehensive. 
Similarly, in the proteomics of the pea symbiosome, NanoESI-Ion Trap-mass pattern-
Protein DB and NanoESI-Ion Trap-mass pattern-EST DB methods were applied, but failed 
to identify almost one half of the proteins, with 46 identifications out of 89 spots analyzed 
from 2-D gels, despite the application of MS/MS methods[198]. In another example, five 
strategies (PMF-mass pattern-Protein DB, NanoESI-Q(q)TOF-mass pattern-Protein DB, 
NanoESI-Q(q)TOF-amino acids-Protein DB, NanoESI-Q(q)TOF-sequence tags-Protein 
DB, and NanoESI-Q(q)TOF-sequence tags-EST DB) were applied simultaneously to 
characterize the African Clawed frog Xenopus laevis microtubule-associated proteome, 
successfully identifying 62 proteins from 55 protein bands from one dimensional gels. 
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        Table 11  Application of Analytical Strategies in Parallel 
Year Proteomics Ref. 
1993 Bacteria Proteomics [177] 
 PMF-mass pattern-Protein DB  
1996 Yeast Proteomics [197] 
 PMF-mass pattern-Protein DB  
 MS/MS-mass pattern-Protein DB  
2001 Maize Proteomics [78] 
 PMF-mass pattern-Protein DB  
 PMF-mass pattern-EST DB  
2002 Pea Symbiosome Proteomics [198] 
 NanoESI-Ion Trap-mass pattern-Protein DB  
 NanoESI-Ion Trap-mass pattern-EST DB  
2002 Human Nucleolus Proteomics [87] 
 PMF-mass pattern-Protein DB  
 MS/MS-mass pattern-Protein DB  
 MS/MS-sequence tag-Protein DB  
 MS/MS-sequence tag-EST DB  
 MS/MS-sequence tag-Genomic DB  
2002 African Clawed Frog Proteomics [199] 
 PMF-mass pattern-Protein DB 
 MS/MS-mass pattern-Protein DB  
 MS/MS-amino acids-Protein DB  
 MS/MS-sequence tags-Protein DB  
 MS/MS-sequence tag-EST DB  
 
 
Representative proteomic studies are shown above. The name of the organism is in bold. The analytical 
strategies that were employed in those particular proteome studies are listed below the name. Researchers who 
conducted these studies are cited in the column on the right and the year of the study in the left hand column. 
The legend of Table 10 describes strategy annotation. 
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3 Conclusion 
Considering the developments in MS informatics presented here, mass spectrometrists can 
begin to systematically develop, apply, and evaluate the effectiveness of these strategies for 
the functional characterization of proteins based upon sequence identity (Figure 19). In 
many proteomics studies, one strategy will produce the greatest number of identifications, 
while alternative methods will produce diminishing returns (but the methods nonetheless 
allow more data to be accumulated in the analysis of mass spectra, increasing the 
confidence of individual protein identifications and adding to the volume of identifications). 
This was demonstrated in the Dunaliella study where MS BLAST identified twice as many 
proteins as Mascot, and subsequent application of MultiTag identified only one more 
protein (see section 2.3). However, in the Xenopus study, MS BLAST identified only three 
more proteins than Mascot, but MultiTag identified almost twice as many as Mascot (see 
section 2.2). This excentuates the fact that each proteomics study has its own qualities, such 
as DB availability and spectra quality, thus multiple strategies must be explored in order to 
develop a set of tools that can identify proteins in many different situations; each alternative 
strategy has the potential to perform a vital function in future proteomics studies. In the 
future, we can expect new MSPs, new spectra-sequence correlation methods, as well as 
perhaps new types of databases to contribute to the proliferation of protein identification 
strategies. We can also begin to predict future strategies that provide new potential for the 
MS community (i.e. currently MS BLAST is being developed for EST and genomic DB 
searching; these strategies will be significant resources where species have catalogued raw 
genomic or EST sequence and limited protein databases, currently this includes dog, 
chicken, Xenopus laevis, and Chlamydomonas, among others). However as a general trend, 
sequence-similarity protein identification methods are able to identify twice as many 
proteins as conventional softwares, producing a significant contribution to proteomics.   
Sensitive and confident protein identification by MS is a never-ending problem. All 
of the world’s species will not have their genomes sequenced, sequence databases will 
always be at various stages of development, and the biological sciences will find new 
specimens to be analyzed at the level of the proteome. However, the inherent homology of 
proteins in phylogenetically related species can be exploited for mass spectrometry-based 
proteomics. In order to thoroughly and sensitively characterize these proteomes, the 
application of multiple analytical strategies provides a successful approach. In the future, 
we can expect that the network between various types of mass spectra and different types of 
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DB sequences will become more and more integrated with the development of these 
informatic approaches. 
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4 Materials and Methods 
4.1 Peptide Tandem Mass Spectrometry for MultiTag Development 
4.1.1 Software 
MT is a stand-alone application on the Microsoft Windows platform. MT code was written 
using C++ language with Microsoft Visual C++ and Microsoft Foundation Classes 
(Microsoft Inc. CA). Sorting and statistical evaluation of ~5,000 hits takes about 1 second 
on the Pentium IV workstation. Dr. Alexander Golod programmed MT.  
 
4.1.2 Sample Analysis 
Proteins in a purified extract from Xenopus laevis oocytes were separated on a one-
dimensional polyacrylamide gel and visualized by staining with Coomassie (4.2.1). Protein 
bands were excised and in-gel digested with trypsin as previously described[200]. Extracted 
peptides were first analyzed by PMF on a Reflex IV (Bruker Daltonik, Bremen, Germany) 
matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometer, 
and obtained peptide mass fingerprints were submitted for DB searching by Mascot (Matrix 
Science Ltd, UK) software[102]. None of the samples were positively identified. Samples 
were further analyzed by nanoelectrospray tandem mass spectrometry on a QSTAR Pulsar i 
Q(q)TOF instrument (MDS Sciex, Canada).  
 
4.1.3 Interpretation of Tandem Mass Spectra and Database Searching 
Sets of uninterpreted tandem mass spectra were used to search databases first with 
Mascot[102] (the conventional software), and when no positive identifications were 
achieved, the spectra were interpreted manually. Sequence tags were determined by the 
interpretation of tandem mass spectra using BioAnalyst QS software (Applied Biosystems, 
CA). DB searching was performed using the PepSea program (a part of the BioAnalyst QS 
package) against a comprehensive non-redundant protein sequence DB downloaded from 
NCBI (ftp://ftp.ncbi.nlm.nih.gov/blast/db/). No constraints on the protein molecular weight 
or species of origin were imposed. The mass tolerance was set to 0.05 Da for fragment ions 
and 0.1 Da for precursor ions. Hits of error-tolerant searches were pooled in a spreadsheet 
(MS Excel) and were encoded by a peptide precursor mass and a letter code for the matched 
regions of the corresponding sequence tag in order to facilitate subsequent processing by the 
MT program. The entire pool of hits was submitted to the MT program for sorting and 
statistical evaluation. MS/MS spectra were further analyzed by MS BLAST sequence-
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similarity DB searches at http://dove.embl-heidelberg.de/Blast2/msblast.html against the 
“nrdb” protein DB. 
 
4.1.4 EST Database Searching  
4.1.4.1 Software Alteraton 
MT-Integrated DB Search Software. The “MTSearch” script was developed to 
automatically generate a list of DB search results from a list of sequence tags; this was 
performed by Dr. Ignat Shilov of Applied Biosystems (Foster City, CA, USA). Tags were 
used for searching a DB in a stringent fashion (matching regions 1, 2 and 3, see figure 5) 
and error-tolerant fashion: a search tolerating a mismatch of the C-terminal mass (matching 
regions 1 and 2); a search tolerating a mismatch of the N-terminal mass (matching regions 2 
and 3); and searches tolerating one mismatch in the amino acid sequence (matching regions 
1 and 3); the hits were additionally encoded by the mass of the precursor ion and by the 
abbreviated matching region (NC, N, C, or E, respectively) in the sequence tag and 
compiled in a list for submission to MT.  
MT Modifications The existing MT software was modified so the average number of tryptic 
peptides DB entry could be specified. The average protein length in a non-redundant DB 
was previously determined to be 492 amino acids (corresponding to ~60kD). The average 
length of a tryptic peptides was designated at 12 amino acids, setting the average number of 
tryptic peptides per DB entry at 41. Since the average length of an EST entry codes for 166 
amino acids (EST_others, Nov. 27, 2002, NCBI), this number was divided by 12 and the 
value for EST DB searching was set at 14. 
 
4.1.3.2 Database Searching 
Mascot queries were generated from tandem mass spectra using the processing script 
Mascot v.1.6b2 as an extension of BioAnalyst QS software (Applied Biosystems). Spectra 
were centroided and peaks were merged at 0.05 Thomsons, and peak lists contained mass 
values from peaks ≥2% base peak. DB searches with Mascot were performed on an internal 
server with a precursor mass tolerance of 0.1 Da and a fragment ion mass tolerance of 0.05 
Da, default precursor charge states were set at +2 and +3, with trypsin enzyme specificity, 
one miscleavage allowed, variable methionine oxidation, fixed carboxyamidomethyl 
cysteine, instrument type set at default, and no restrictions for protein molecular weight, but 
restricted to DB entries from the species Xenopus laevis. The Mascot identifications were 
made using the Peptide Summary Report for enhanced sensitivity.  
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Sequence tags were generated as previously using the Bioanalyst QS software. MT 
searches were performed using the PepSea software as a part of BioAnalyst QS, with a 
precursor mass tolerance of 0.1 Da and a fragment ion mass tolerance of 0.05 Da, with 
trypsin enzyme specificity, and fixed carboxyamidomethyl cysteine. Search results were 
analyzed with the MT software described above. MT parameters were set: 1,396,530 DB 
entries searched (6 frames X 232,755 Xenopus laevis EST entries), 0.1 Da mass accuracy, 
and 14 for number of peptides per entry. MT has no species restriction parameter and 
therefore all cross-species alignments were ignored.  
Both methods searched the same DB EST_others (November 27, 2002), from the 
National Center for Biotechnology Information, and only used the Xenopus laevis subset of 
this DB. The identity of all ESTs was verified by blastx DB searches at the NCBI internet 
site.  
 
4.2 Xenopus Experiments 
4.2.1 Purification of MAPs From Xenopus Egg Extract.  
Mitotic MAPs were prepared by Dr. Andrei Popov in the laboratory of Professor Eric 
Karsenti. The complete procedure is described in[199]. Mitotic Xenopus egg extracts were 
prepared according to A. Murray[97]. Assembled microtubules were prepared with pig 
brain tubulin and stabilized by addition of Taxol and pelleted. To bind MAPs and motors to 
microtubules, the extract was incubated with prepolymerized microtubules, plus GTP and 
AMP-PNP (Adenosine-5'-imidotriphosphate). AMP-PNP, a non-hydrolysable analogue of 
ATP, was shown to stabilize motors interaction with microtubules[201]. The microtubule 
pellet was collected and prepared by SDS-PAGE. 
 
4.2.2 Mass Spectrometry Analysis.  
Individual protein bands were in-gel digested with trypsin as previously described[200]. 
Collected peptides were analyzed first by peptide mass mapping on a Bruker Reflex IV 
MALDI TOF mass spectrometer. Peptide mass maps were searched against NCBI’s protein 
DB (MSDB) using the Mascot server ver.1.8[102] with a mass tolerance of 150 ppm. No 
search parameters were imposed to limit species-specificity for all searches. Proteins not 
identified by peptide mass mapping were subjected to MS/MS analysis by nanoelectrospray 
mass spectrometry.  All MS/MS spectra were first used for DB searches with Mascot at a 
tolerance of 0.1 Da for the precursor mass and 0.05 Da for fragment ion masses. All 
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MS/MS spectra were then used for DB searches with MS BLAST (http://dove.embl-
heidelberg.de/Blast2/msblast.html) against a protein DB (nrdb95), and then finally again 
analyzed by MT (Table 1). For MS BLAST, BioAnalyst software from Applied Biosystems 
(Foster City, CA) predicted de novo amino acid sequences with a tolerance of 0.1 Da for the 
precursor mass and 0.05 Da for fragment ion masses. The MSBlast processing script 
(version 1.1beta) automatically generated peptide sequence queries from MS/MS spectra for 
the MS BLAST DB searches. For MT interpretation, sequence tags were manually 
constructed, using BioAnalyst, from abundant y-ion series with m/z usually larger than the 
precursor ion in MS/MS spectra. All sequence tags contained 2-5 amino acid residues 
within the tag.  Complete sequence tags (containing all three regions) were first searched 
against NCBI’s protein nonredundent DB (March 6, 2002) and NCBI’s EST_others DB 
(March 6, 2002) using PepSea DB searching and subsequent MT analysis as previously 
described[91].  
 
4.2.3 Density Gradient Fractionation.  
The motor fraction was prepared above. Proteins were then eluted by addition of ATP, 
concentrated by centrifugation, and resolved on 5-45% sucrose gradients. Fractions were 
collected manually from the top of the tube and analyzed on an SDS 6-20% polyacrylamide 
gradient gel. This experiment was completed by Dr. Andrei Popov in the laboratory of 
Professor Eric Karsenti, and the complete procedure is described in[199].  
 
4.2.4 Immunoblot Analysis. 
SDS-PAGE resolved proteins were transferred onto nitrocellulose membranes and probed 
with antibodies by Dr. Andrei Popov in the laboratory of Professor Eric Karsenti, and the 
complete procedure is described in[199].  
 
4.2.5 Motor Fraction Isolation in the Presence of p50.  
Taxol-stabilized microtubules were prepared as described above. The p50 experiment was 
completed by Dr. Andrei Popov in the laboratory of Professor Eric Karsenti, and the 
complete procedure is described in[199].  
 
4.2.6 Spindle Assembly and Electron Microscopy.  
The anaphase spindle was prepared from Xenpous laevis egg extracts and analyzed by 
electron microscopy. Electron micrographs were compared with rough endoplasmic 
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reticulum in the same field for particle comparison. This experiment was completed by Dr. 
Peg Coughlin in the laboratory of Professor Tim Mitchison, and the complete procedure is 
described in[199].  
 
4.3 Dunaliella salina Experiments 
4.3.1 Cellular fractionation 
Algae were cultured in 0.5 M NaCl medium for control conditions and at 3M NaCl medium 
for induced conditions. Cells were fractionated into crude plasma membrane, cytoplasmic 
soluble, and chloroplast soluble as described in[202]. These experiments were completed by 
Dr. Adriana Katz in the laboratory of Professor Uri Pick. 
 
4.3.2 Two-Dimensional (2D) PAGE 
Isolated proteins were resolved by 2-D PAGE as desribed in[202]. The intensity of protein 
spots from the 3 M and 0.5 M control gels were compared. Spots up regulated more than 2-
fold were selected for analysis by MS. These experiments were completed by Dr. Adriana 
Katz in the laboratory of Professor Uri Pick. 
 
4.3.3 Mass Spectrometry Analysis of Protein Spots  
Individual protein spots were manually excised from 2-D gels and in-gel digested with the 
protease trypsin as previously described[200]. Extracted protein digests were analyzed first 
by PMF on a Bruker Reflex IV matrix-assisted laser-desorption ionization time-of-flight 
(MALDI-TOF) mass spectrometer in reflectron mode and anchor-chip sample 
preparation[203]. Resulting peptide mass fingerprints were used for DB searching. Proteins 
unidentified by PMF were analyzed by nanoelectrospray tandem mass spectrometry on a 
modified MDS Sciex QSTAR Pulsar i quadruple time-of-flight (QqTOF) instrument, using 
uncoated borosilicate glass capillaries (1.2mm O.D. X 0.69mm I.D.) from Harvard 
Apparatus Ltd (capillaries were drawn in-house on a Sutter P-97 puller).  
 
4.3.4 Database Searching 
Peptide mass fingerprints were used for DB searching by Mascot[102] against the MSDB 
DB from NCBI (February, 2003), with a mass tolerance of 150 ppm; no restrictions were 
imposed for protein molecular weight; species set to “Green Plants”. Sets of tandem mass 
spectra from the analysis of unidentified proteins were first searched by Mascot against the 
above DB to identify proteins with peptides identical to those existing in silico, at a 
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precursor mass tolerance of 0.1 Da and fragment ion mass tolerance of 0.05 Da, as above. 
Mascot queries were generated from MS/MS spectra using the processing script Mascot 
v.1.6b2 as an extension of Bioanalyst QS software from Applied Biosystems (Foster City, 
CA). Mascot EST DB searching used "Other Green Plants" EST_others (Nov. 27, 2002). 
All tandem mass spectra were then analyzed by MS BLAST against the non-redundant nrdb 
protein DB at http://dove.embl-heidelberg.de/Blast2/msblast.html, as previously 
described[62]. Amino acid sequences were predicted with 0.1 Da tolerance for precursor 
masses and a 0.05 Da tolerance for fragment ions using Bioanalyst QS.  Queries for MS 
BLAST DB searches were generated from MS/MS spectra using the ProBLAST v.1.0b11 
data processing script as an extension of Bioanalyst QS[63]. In cases where scripted MS 
BLAST methods failed to identify a protein, an MS BLAST query was generated by manual 
interpretation of MS/MS spectra using Bioanalyst. If the analyzed protein remained 
unidentified after PMF, Mascot, and MS BLAST DB searching with queries derived 
automatically and manually from MS/MS data, peptide sequence tags were constructed 
from MS/MS spectra by manual interpretation using Bioanalyst QS for DB searching and 
MultiTag analysis of search results[91].     
 
4.4 MS BLAST Specificity and Phylogenetic Analysis 
4.4.1 Computing of MS BLAST Specificity and Phylogenetic Analysis.  
The following analysis was performed by Bianca Habermann of MPI-CBG, Dresden. MS 
BLAST searches with standard settings were carried out for 1000 proteins from several 
model organisms (S. cerevisiae, S. pombe, C. albicans, T. rubripes, R. norvegicus, M. 
musculus and H. sapiens) using eight randomly selected peptides per DB entry. A non-
redundant DB was prepared such that all sequences from the organism under analysis were 
omitted. Further trials using only the next closest species as a reference DB and not the total 
set of non-redundant proteins showed no significant increase or decrease in the success rate 
of identifications (data not shown). To estimate the success of MS BLAST searches, queries 
comprised of 8 peptides sequences were used, 10 amino acids in length and with 2 errors in 
each peptide to simulate ambiguities in spectrum interpretation. The top hit of each MS 
BLAST search was collected and tested for positive or negative identification, whereby 
threshold values for MS BLAST searching were calculated, essentially as published 
previously[62], with the exception that the reversed non-redundant DB downloaded from 
NCBI (release of August 2001) was used. A phylogenetic tree of a selected set of organisms 
from three subkingdoms was constructed based on mitochondrial small ribosomal RNA. 
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Multiple sequence alignments were made using the program ClustalX[204], and the 
phylogenetic trees were constructed with the programs dnadist and fitch, both from the 
Phylip package[205]. The estimated success rate of MS BLAST identification was 
correlated with phylogenetic distances between a model set of organisms and was applied to 
a larger set of organisms on a phylogenetic tree. 
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